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ABSTRACT
INVESTIGATION OF POTENTIAL MECHANISMS UNDERLYING SPINAL
CORD INJURY-INDUCED POLYURIA

Jason H. Gumbel
September 15, 2021
Spinal cord injury (SCI) results in neurological impairments including
motor, sensory, and autonomic dysfunction. These neurological deficits result in
a litany of complications apart from muscular paralysis, including bladder, bowel,
cardiovascular, and sexual function. SCI-induced polyuria (the
overproduction/passage of urine) remains understudied, and therefore
mechanisms behind it are largely unknown and require extensive investigation
for potential targeted therapies to improve quality of life.
The objective of this dissertation was to investigate potential mechanisms
of SCI-induced polyuria and explore potential therapies to improve quality of life
in the SCI population. Metabolic cages, Western blot, enzyme-linked
immunoassay, and immunostaining were first used to determine the timing of
fluctuations in biomarkers associated with SCI-induced polyuria, including
arginine vasopressin (AVP), atrial natriuretic peptide (ANP), vasopressin 2
receptor (V2R), natriuretic peptide receptor A (NPRA), and epithelial sodium
channel (ENaC). Next, to identify which neural substrates induce polyuria with a
T9-level SCI, a higher level (T3) contusion above the local sympathetic supply to
v

the kidneys were also examined. Lastly, the effect of anantin (NPRA antagonist)
on SCI-induced polyuria was explored, in addition to utilizing an established
treadmill activity-based recovery training (ABRT) program.
There were significant alterations of multiple biomarkers after SCI,
beginning at 7 days post injury (dpi), in addition to a lower number of AVPlabeled neurons in the hypothalamus. By 7 dpi, continuing through 6 weeks postSCI, T3 contused rats showed a significant increase in 24-hour void volume as
well as significant changes in ANP and AVP like the T9 injury. There was also a
significant decrease in AVP-labelled cells in the suprachiasmatic nucleus post-T9
and T3 contusion relative to controls. A reduction in void volume was found for
rats having ABRT but not anantin treatment. A significant decrease in mean
arterial pressure was measured in all animal groups lasting chronically, and there
was a significant increase in serum potassium at 14 dpi in addition to a significant
decrease in serum sodium at the chronic time point. Together, these studies
provide a detailed account of systemic responses to SCI that are associated with
SCI-induced polyuria and fluid homeostasis.
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CHAPTER I
GENERAL INTRODUCTION
Hormonal events and spinal cord injury: a focus on vasopressin and natriuretic
peptide

Spinal cord injury (SCI), which directly damages one system of the body
(the nervous system), precipitates a whole-body disease, affecting all other major
bodily systems including the circulatory, digestive, endocrine, immune, muscular,
renal, reproductive, respiratory, and skeletal systems. Although the effects of SCI
on musculoskeletal system deficits have historically received a lion’s share of the
attention with respect to pre-clinical and clinical research, studies focused on
other bodily systems have been more limited, with relatively few considerations
of cross-system interactions. The current chapter reviews the SCI literature todate that has focused on the endocrine system, with a specific emphasis upon
the dysregulation of two neurohormones, vasopressin and atrial natriuretic
peptide. These hormones influence multiple systems (cardiovascular, renal and
urinary), and resulting deficits impact both daily activities and quality of life.

Gumbel, J.H., Hubscher, C.H. (2021). Hormonal events and spinal cord injury: a
focus on vasopressin and natriuretic peptide. The Neuroscience of Spinal
Cord Injury. (in press).
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Dysfunctions of the upper and lower urinary tracts that arise after SCI
include detrusor-sphincter dyssynergia, incontinence, polyuria, urinary retention
and loss of sensation. Bladder emptying methods include intermittent
catheterization (self or by an attendant), indwelling catheters (transurethral or
suprapubic), reflex triggering, straining, manual compression (Crede), and sacral
anterior root stimulation. A poorly understood complication that develops after
SCI which impacts the daily frequency of conducting these management
techniques is polyuria, the overproduction and/or passage of urine, which has
been documented in both human SCI and pre-clinical contusion models. [1-4]
This excessive volume of urine requires more frequent catheterizations,
increases the risk of bladder and urinary tract infections, and prompts the need
for nightly awakenings for bladder emptying (nocturia) which is disruptive to sleep
and receiving enough rest. Often times, SCI individuals will limit their fluid intake
to avoid nocturia, which introduces further and potentially more serious
confounding issues such as dehydration, which exasperates bowel management
through constipation, and autonomic dysreflexia, a life-threatening sudden
increase in arterial blood pressure that is elicited by noxious (e.g., pain) and/or
innocuous stimuli (e.g., bladder filling) from below the level of injury. [5, 6]
The underlying mechanisms of polyuria/nocturia are unknown, but likely
includes arginine vasopressin (AVP; also commonly referred to as anti-diuretic
hormone), which regulates urine production and fluid homeostasis and has
recently been shown to correlate with the incidence of SCI-induced polyuria. [7,
8] However, it remains undetermined what directly causes the decrease in AVP
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after SCI, as there are likely multiple factors contributing to polyuria (Figure 1).
These factors include the natriuretic peptides (NP), such as atrial natriuretic
peptide (ANP), brain-derived natriuretic peptide (BNP), and C-type natriuretic
peptide (CNP).
The focus of the current chapter review is upon SCI-induced changes in
AVP and ANP as they play a major role in water/electrolyte balance. In addition,
these neurohormones also impact the cardiovascular system. Substantial
cardiovascular deficits present amongst the SCI population include orthostatic
hypotension, bradycardia, daily fluctuations in blood pressure, and autonomic
dysreflexia. [3, 9, 10] Given these multiple functional roles of neurohormones,
any imbalance is likely to impact the overall well-being of the SCI population.
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Function of vasopressin (AVP)
One of the bodies most important hormones required for the regulation of
salt and water balance is AVP. The production of AVP takes place within neurons
located in the supraoptic nucleus (SON), suprachiasmatic nucleus (SCN), and
paraventricular nucleus (PVN) of the hypothalamus, regions of the brains limbic
system having a central neuroendocrine function. [11, 12] These hypothalamic
neurons terminate in the posterior lobe of the pituitary and release AVP in
response to several different stimuli. First, under normal physiological
circumstances, osmoreceptors located in the hypothalamus respond to an
increase in blood osmolality (occurs with dehydration or a high sodium diet) [13,
14] through physical shrinkage which triggers a signaling cascade to release
AVP from the pituitary. Within the kidney, vasopressin 2 receptors (V2R) respond
to elevated AVP circulating in the blood by increasing reabsorption of solute-free
water back into the circulatory system through the opening of aquaporin 2
(AQP2) channels, which results in a decrease in urine volume. As many as
thirteen different types of aquaporins have been identified in mammals, of which
at least seven are located within the kidney and function to transport water
across membranes. [15] However, AQP2 is the only kidney aquaporin known to
be regulated by AVP.
There are three main AVP receptors: V1, V2, and V3. Each of these
receptors has specific functions within different regions of the body. The V1
receptor (V1R) is mainly located in vascular smooth muscle and platelets, but
can be found in brain, testis, superior cervical ganglion, liver, blood vessels, and
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kidney. [16] Functionally, the V1R is a G protein-coupled receptor and utilizes the
activation of calcium influx, phospholipase A2, phospholipase C, and
phospholipase D. The V1R functions mostly as a vasoconstrictor and in
thrombosis, but has been shown to be associated with myocardial hypertrophy,
glycogenolysis, and uterine contraction. [17] V1Rs can also be found in the
kidney where it also functions to promote vasoconstriction within the efferent
arterioles, which reduces glomerular filtration rate.
The V2 receptor (V2R) is primarily located within the kidney and promotes
a strong antidiuretic effect. As illustrated in Figure 2, upon the binding of AVP to
kidney V2 receptors, cAMP is activated which then triggers the fusion of AQP2
channels to the apical membrane of the collecting ducts. [18] The increase in
AQP2 channels promotes water reabsorption. For this reason, V2R is a target of
pharmacological therapies to decrease urine production in cases like diabetes
insipidus [19] and SCI. [20, 21] V2R is also located in vascular endothelium and
smooth muscle cells and has vasodilation properties.
The V3 receptor (V3R) is also a G protein-coupled receptor but is far less
distributed than either V1R or V2R. Less is known about V3R, but it is
overexpressed in adrenocorticotropic hormone (ACTH)-secreting tumors.
Additionally, its function is dependent on the concentration of AVP. One function
of V3R is to promote ACTH release from the pituitary, but at other concentrations
of AVP, V3R can increase DNA and cAMP synthesis, which is seen in tumor
growth.
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Function of natriuretic peptides (NP)
NPs include three structurally and functionally related hormone factors:
ANP, BNP, and CNP, although there is evidence of a fourth, Dendroaspis
natriuretic peptide (DNP, isolated from the green mamba snake). The primary
function of NPs is to promote natriuresis. [22] Natriuretic peptide receptor A
(NPRA) is the primary receptor for all three NPs. Although primarily found in the
kidney as its function is to promote diuresis and natriuresis, NPRA is also located
in lung, vasculature, heart, adrenal, adipose, and brain tissues. [23-25] The
ANP/NPRA interaction regulates blood pressure, and therefore is essential for
fluid balance homeostasis.
The release of both ANP and BNP is triggered by an increase in blood
volume within the heart. While ANP is released primarily within the atria, BNP is
released within the ventricles. Although ANP and BNP have a similar function,
BNP has an estimated 10-fold lower affinity than ANP, and therefore is
considered a weaker diuretic. Clinically, serum ANP is used as a biomarker for
cardiovascular disease, including myocardial infarction, stroke, coronary artery
disease, and heart failure. [26-28] In clinical SCI research settings, ANP has
been investigated as a therapeutic in ischemia/reperfusion injury, [29] as well as
for its role in exercise therapy [30] and bladder distention. [30] Further work is
necessary to elucidate the importance and extent to which the changes in these
peptides after SCI affect urinary and cardiovascular health.
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SCI-induced polyuria/nocturia
Nocturia is defined as the necessity to void one or more times at night,
specifically while sleeping. [31] There are many potential causes of nocturia,
including decreased bladder capacity, increase in fluid intake, and increased
diuresis. [32] A common occurrence in the human SCI population is nocturnal
polyuria, or an excess of urine production/passage at night. [8] This issue causes
sleep disruptions, bladder overdistention, and an increased risk of acquiring
lower urinary tract infection due to the necessity for additional intermittent
catheterizations. Historically, SCI-induced polyuria was thought to be the effect of
decreased vascular tone and pooling of fluid in the lower extremities, which upon
fluid redistribution when supine at night-time causes “intravascular flooding” and
subsequent diuresis. [33, 34] However, polyuria is present in animal SCI models
[2, 4, 7, 35] which lack positional fluid redistribution, suggesting that other
mechanisms are likely involved.
In chronic SCI patients, increased blood pressure at night versus day is
associated with increased nighttime urine production. [36] Further, nocturnal
polyuria, SCI-induced or otherwise, can be caused by decreased AVP circulation,
increased ANP, and cardiovascular insufficiency. [37] A study by Denys et al.
revealed that SCI patients lacked circadian control of renal function (clearance of
creatinine, free water, and solutes). [8] Together, these measured changes in
circadian control of renal function, blood pressure, AVP, and ANP after SCI are
all likely contributing to the mechanisms driving SCI-induced polyuria.
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AVP after SCI
One potential factor that contributes to SCI-induced polyuria is a decrease
in levels of AVP. Under normal conditions, humans exhibit an increase in
circulating AVP at night which results in decreased sleep-time urine production
and thus volume, thereby controlling the need for toileting. Clinically, children
with nocturnal polyuria experience disruptions in the diurnal variation of AVP,
specifically a decrease in circulating AVP, causing an abnormal increase in nighttime urine production which may induce bed-wetting. [38] Similarly, the SCI
population commonly experience disrupted diurnal variation of AVP, [1, 39]
leading to the need for bladder emptying one or more times a night. Additionally,
individuals with SCI exhibit disrupted circadian control of renal creatinine
clearance, water diuresis, and solute diuresis. [8] This decrease in night-time
AVP is likely a major contributor to SCI-induced polyuria/nocturia. Furthermore,
persons with injuries above T6 tend to demonstrate an increase in nocturnal
sodium excretion, which would suggest that the mechanisms behind SCI-induced
polyuria include other factors such as ANP/BNP. [8] However, polyuria has also
been observed in individuals having varying severities and injury levels, trends
consistent with metabolic cage results in the clinically relevant rat contusion
model whereby polyuria was measured regardless of extent of injury. [2]
In order to further elucidate the potential mechanism of SCI-induced
polyuria, pre-clinical experiments were conducted to investigate the changes in
AVP and NP’s in the rat SCI model. The reported data [7] are consistent with
those described for the human SCI population. At two-weeks post SCI, male rats
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demonstrated a significant decrease in serum AVP, [7] which continued at a
chronic time point as well. [35] In addition to the sub-acute and chronic decrease
in AVP, the key AVP receptor in the kidney, V2R, was significantly lower than
uninjured surgical sham rats. [35] This result is somewhat surprising as V2R is a
G-coupled protein receptor and under normal physiological conditions, becomes
desensitized to an abundance of its ligand (in this case, AVP), and inversely
becomes sensitized under low levels of its ligand. Moreover, as illustrated in
Figure 2, protein levels of AQP2 channel and epithelial sodium channel (ENaC)
within the kidney were also reduced along with V2R, further highlighting the
importance of AVP in SCI-induced polyuria, as AQP2 channels are formed in
response to the activation of V2R to promote water absorption, and ENaC
functions to reabsorb sodium ions back into the blood stream. Taken together,
the changes in these receptor densities after SCI, as shown in Figure 3 and 4,
are in the direction expected to promote polyuria.
A significant increase in AVP has also been reported in female piglets 15
minutes after a cervical spinal transection, which is likely an acute response to
cardiovascular changes to maintain homeostatic blood pressure. [40] This finding
demonstrates that the hemodynamic changes seen after SCI are likely affecting
the changes in AVP, as orthostatic hypotension is another common occurrence
in the human SCI population. [9, 41, 42].
While desmopressin (a synthetic AVP analogue) is used to suppress bed
wetting in children [43] and has yielded positive results in some cases of SCIinduced nocturnal polyuria, [21, 44] it’s use may be limited to those at lower risk
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of cardiovascular disease. Additionally, desmopressin only targets one of the
several potential factors that lead to polyuria and leaves other pathways
unchecked, such as ANP/NPRA.

10

ANP after SCI
Mechanisms driving the chronic decrease in AVP/V2R after SCI are
unknown. Although blood osmolality is one driving force behind AVP release,
non-osmotic stimuli such as NPs, glucocorticoids, and norepinephrine may
control AVP levels and urine production. [45, 46] Of these stimuli, NPs
(ANP/BNP) and corticosterone (CORT; primary glucocorticoid in rats) have been
further investigated in the rat SCI model (see Figure 1). While there is some
evidence that SCI can induce changes in ANP in the clinical setting, [47] further
pre-clinical and clinical experimental studies are necessary to further elucidate
the impact of level and severity of injury.
Changes in urinary ANP and CORT have been documented as early as
two weeks after a moderate contusion injury in male rats, together with serum
AVP. [7] In a 2018 study of SCI rats with polyuria, both urinary ANP and CORT
were significantly increased two weeks post-contusion, while surgical sham
animals demonstrated no differences. Both ANP and CORT inhibit the function
and release of AVP, therefore the significant changes in these hormones
(increases in ANP and CORT and a decrease in AVP) are in the direction
expected with respect to polyuria. [48, 49] It is important to note that urinary BNP
levels have not been shown to change after SCI. However, BNP is a weaker
diuretic compared to ANP. It cannot be ruled out that plasma BNP changes occur
after SCI, as its half-life is relatively short and potentially difficult to capture.
It has also been demonstrated that the significant changes in AVP and
ANP continue chronically in SCI male rats. [35] In a recent study, SCI animals
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having polyuria were randomized into one of two groups receiving different forms
of activity based recovery training (ABRT) on a treadmill or one of two groups
having no therapeutic intervention (one group harnessed without any treadmill
activity and one remaining in their home cage). [50] While all groups still
demonstrated polyuria at the end of the study such that their 24-hour urine
volumes remained significantly increased from baseline pre-injury levels, the
ABRT animals showed a significantly lower 24-hour urine volume than the nontrained animals after the eight weeks of daily 60-minute training sessions. These
findings were similar to those previously reported in animal [4, 51] and human
studies [52] demonstrating multisystem benefits of locomotor training. In addition
to changes in AVP, ANP and corticosterone, relative expression densities of
NPRA was found to be significantly increased in the non-trained animals, but not
the ABRT animal groups (see Figure 3). The inverse was found for V2R and
AQP2 as their expression were significantly decreased in only the non-trained
animal groups, while the ABRT animals were not significantly different from
surgical sham animals. These findings, illustrated in Figure 3, suggest that one
potential mechanism behind the improvement in polyuria after exercise therapy is
the regulation of key receptors within the kidney. Note that although highintensity exercise induces an acute increase in AVP in able-bodied subjects [53,
54] as well as ANP, [55] these effects may be short-lived and may differ under
conditions such as SCI. More studies are needed to further elucidate underlying
mechanisms.
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Potential mechanisms causing changes in AVP and/or ANP after SCI
Although many variables lead to the release of AVP, two important
physical changes include hypertonicity and/or hypovolemia, which are important
because orthostatic hypotension is a common occurrence amongst the SCI
population. [9] Another issue for the SCI population, specifically with higher level
injuries, is autonomic dysreflexia (AD), a sudden onset of hypertension. [56]
Repeated and frequent occurrences of AD may have an impact on AVP release
and subsequent concentration of V2R in the kidney. Such changes in alpha
adrenergic receptors (receptors for epinephrine and norepinephrine) have
already been linked to AD. [57] AD has also been characterized following severe
injuries in the rat model of SCI. [58]
One potential mechanism behind the observed increase in NPRA after
SCI in rodents [35] is an increase in glucocorticoids. An increase in
glucocorticoids can increase glomerular filtration rate, [48] decrease the level of
plasma AVP, upregulate NPRA within the kidney, [59] and increase ANP release.
[60] Corticosterone, the main glucocorticoid in rodents (equivalent to cortisol in
humans), is elevated in both humans and rodents after SCI, which could relate to
stress. [61, 62] It is also documented that glucocorticoids have the ability to alter
immune activity, whereby a significant increase may lead to immunosuppression.
[63-65] After SCI, specifically high-level injuries, elevated glucocorticoids are
associated with a significant decrease in immune responses, which can lead to
an increased risk of infections, including that of the bladder and kidney. [66]
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It is noteworthy that the renin aldosterone angiotensin system (RAAS) also
regulates cardiovascular homeostasis (blood pressure and volume) in addition to
fluid and electrolyte balance (urine concentration and excretion). RAAS is an
additional factor that can affect both AVP and ANP, and therefore needs further
investigation in its potential role in SCI-induced polyuria. While there are studies
in the clinical setting that indicate there are acute changes in renin and
aldosterone after SCI, [67, 68] the focus of these studies relate to cardiovascular
function.
Redistribution of body fluids in the SCI population at bedtime when shifting
from a sitting to supine position produces cardiovascular fluctuations, which in
turn affects the delicate hormone balance that controls homeostatic fluid balance.
[69] This fluid redistribution is one potential mechanism of SCI-induced polyuria.
Support comes from a study where use of compression stockings was shown to
reduce leg edema during the day and subsequent urine production during the
night. [69] However, animal models with SCI-induced polyuria that do not
undergo fluid redistribution suggest other mechanisms are likely involved, such
as hormones previously identified with respect to fluid balance (see Figure 1). As
further research progresses, additional key hormones/receptors will be identified
along with AVP and ANP, and their roles elucidated with respect to SCI-induced
polyuria as well as cardiovascular health.
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Applications to Other Areas of Neuroscience
Several associations have been made between altered AVP function and
several neurological disorders besides SCI, including autism, depression, bipolar,
and schizophrenia. [70] For example, altered binding of AVP and V1R in the CNS
has been linked to autism disorders, [71] and elevated CSF levels of neurophysin
II (hypothalamic carrier protein for AVP) were found in patients with
schizophrenia. [72] Also, in multiple sclerosis, an autoimmune disorder that
affects the myelin sheaths of nerves within the CNS, urinary tract dysfunctions
include polyuria/nocturia. [73] The potential mechanisms behind multiple
sclerosis associated polyuria overlap with SCI-induced polyuria, such as
disrupted AVP secretion and nocturnal hypertension. [74]
Other neurological involvement related to NPs have been shown for
studies involving the olfactory bulb, [75] Purkinje fibers of the cerebellum, [76] the
retina, [77] and development. [78] There have also been studies indicating a
potential neuroprotective role for NPs, likely through increasing cGMP levels. [78,
79] Together, it is clear that both NPs and AVP are two critical entities that
should be considered in other settings in addition to SCI.
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Experimental Directions
The objective of this dissertation is to investigate the mechanisms and
explore potential therapeutic targets for SCI-induced polyuria using a pre-clinical
animal model. Currently, it is unknown when the previously identified biomarkers
(AVP, ANP, V2R, NPRA, AQP2, and ENaC) involved in SCI-induced polyuria are
significantly altered. Therefore, the timeline of fluctuations in specific biomarkers
associated with the incidence of SCI-induced polyuria was investigated by
carrying out enzyme-linked immunosorbent assay (ELISA), Western blot,
immunohistochemistry, and 24-hour metabolic cage experiments on selected
tissue and samples derived from SCI animals on 3, 7, 14, 28, 42, and 84 days
post injury (dpi) compared to surgical sham controls. It was hypothesized that
SCI-induced polyuria-associated biomarkers in the kidney and hypothalamus
(specifically AVP) would be altered post-SCI and remain imbalanced chronically.
Secondly, the incidence and extent of polyuria, along with AVP and ANP levels
after a T3 level injury was explored in order to determine if level of injury plays a
role in SCI-induced polyuria, as a high thoracic injury (T3) will disrupt only
supraspinal sympathetic input to the kidneys, rather than both supraspinal and
preganglionic sympathetic fibers with a low thoracic injury. It was hypothesized
that a T3 level SCI would result in a significant disruption of urinary function,
including SCI-induced polyuria in conjunction with altered AVP/ANP levels.
Lastly, the NPRA antagonist anantin was administered, with and without the
addition of ABRT to determine if NPRA could be a potential target for
pharmacological intervention in reducing the effect of SCI-induced polyuria.
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Additionally, secondary outcomes measures, such as mean arterial pressure
(MAP), serum sodium, and serum potassium were measured to record any
potential effects of either anantin and/or ABRT in SCI rats. It was hypothesized
that the combination of ABRT and anantin would decrease polyuria compared to
the vehicle treated and non-trained animals, in addition to significant changes in
MAP, sodium, and potassium levels. Together, these experiments provide further
insight into understanding the mechanisms behind the incidence and
maintenance of SCI-induced polyuria, in addition to providing details of systemic
occurrences that contribute to urologic health.
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Figure 1:
Key hormone/receptors in fluid balance and how they are affected after SCI.
Depiction of key hormones such as AVP, NPs, and CORT, along with paired
receptors such as NPRA, V2R, AQP2, and ENaC, and how they contribute to
fluid balance/homeostasis. In the non-injured state, these hormones and
receptors work together to closely regulate fluid balance. After injury,
dysregulation occurs leading to an overproduction of water (polyuria/nocturia).
Changes in the opposite direction would cause a decrease in urine production
(oliguria).
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Figure 2:
Diagram of AVP/ANP and their receptors within the kidney under normal
physiological conditions and after SCI. As part of normal physiological processes
to maintain fluid homeostasis, AVP is released by the hypothalamus in response
to conditions of hyperosmolality (A, upper portion). Once in the kidney, AVP
binds to V2R, which triggers a response to open AQP2 channels to allow water
flow from the kidney collecting duct back into the epithelium while ENaC allows
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for sodium to be reabsorbed. However, under conditions of elevated blood
volume, ANP is released from the heart (A, lower portion) and upon binding to
NPRA within the kidney, a cascade is triggered to permit salt and subsequently
water excretions. As illustrated in B, there is a decrease in AVP, V2R, and ENaC
as well as an increase in ANP and NPRA after SCI, which together contribute to
the injury-induced occurrence of polyuria/nocturia.
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Figure 3:
Activity-Based Recovery Training reverses several key fluid balance receptors in
the kidney after SCI. After chronic SCI, V2R, NPRA and AQP2 are significantly
altered. Relative expression of proteins using Western blot reveals that V2R and
AQP2 are significantly decreased while NPRA is significantly increased in groups
of male Wistar rats that did not receive any therapeutic interventions (NT = nontrained; HC = home cage) after a moderate-severe contusion injury that yields
approximately 11% white matter sparing at the T9 spinal level lesion epicenter.
Animals that received ABRT involving quadrupedal or forelimb-only training (QT
and FT, respectively) by stepping on a treadmill for one hour a day, 7 days a
week for 8 weeks beginning two weeks post-injury were found to have similar
levels of these receptor/channel densities to surgical sham animals (spinal
laminectomy but no contusion).
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Figure 4:
Activity-Based Recovery Training reverses ENaC β and γ subunits deficit after
SCI. After chronic SCI, both β and γ subunits of ENaC are significantly
decreased. However, after ABRT (SCI+FT and SCI+QT), the relative density of
both β and γ subunits were reversed to similar levels of surgical sham animals.
Group abbreviations per Figure 3.
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CHAPTER II
TIMELINE OF CHANGES IN BIOMARKERS ASSOCIATED WITH SPINAL
CORD INJURY-INDUCED POLYURIA

Introduction
Spinal cord injury (SCI) results in deficits that are widespread across all
bodily systems, including those involving motor, sensory, autonomic, endocrine,
and immune functions. Urologic dysfunctions are rated by SCI individuals as one
of the most important factors impacting quality of life. [80] However, the vast
majority of pre-clinical and clinical studies targeting the urinary system have
focused on the lower urinary tract (bladder, urethra, and external urethral
sphincter), with relatively fewer studies addressing deficits related to the upper
urinary tract (kidney) post-SCI. A common issue that arises after SCI that
complicates urinary function is the excess production/passage of urine
(polyuria/nocturia), [81] which has been reported clinically and in pre-clinical
animal models. [2, 4, 8, 82] The frequency of daily bladder catheterizations,
including during the night-time, is disruptive to daily activities and sleep while
simultaneously increasing the risk of urinary tract and bladder infections. [83]
However, many persons with SCI accommodate by limiting their intake and/or

Gumbel J.H., Yang C.B., and Hubscher C.H. (2021) Timeline of changes in key
hormones and their receptors associated with spinal cord injury-induced
polyuria after spinal cord injury. Neurotrauma Reports. (in press)
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type of fluids, which complicates the estimation of polyuria prevalence and
can lead to dehydration or other issues impacting health. [84]
Our group has previously shown using a pre-clinical animal incomplete
contusion model that 1) polyuria occurs regardless of severity of SCI, [2] 2)
alterations of hormones affecting diuresis are present at 14 days’ post injury
(dpi), [7] and 3) related receptor/channel densities are altered in the kidney at 10
weeks post-SCI. [35] Although several key hormones and their receptors in the
kidney impacting fluid balance have been shown to contribute to the mechanisms
underlying SCI-induced polyuria/nocturia, more information is needed for the
optimization of therapeutic approaches. [7, 35]
Several studies have already been published to date demonstrating
significant disruptions in arginine vasopressin (AVP, also commonly referred to
as anti-diuretic hormone), atrial natriuretic peptide (ANP), and their associated
receptors (V2R and NPRA, respectively) in the kidney after SCI. [1, 7, 35] We
have also shown that kidney aquaporin 2 channels (AQP2) and epithelial sodium
channels (ENaC) were significantly decreased following SCI in adult male rats.
[35] Together, these fluctuations in AVP and ANP and their accompanying
receptors/channels lead to an increase in urine production based on their
physiologic function. These receptors also play major roles in salt and fluid
balance within the body, as well as cardiovascular homeostasis. [85, 86]
Clinically, desmopressin (synthetic AVP) may be used to treat nocturnal polyuria,
but with limited results and potential deleterious side-effects. [20, 87] Additionally,
desmopressin often impacts blood pressure, which may increase bouts of
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autonomic dysreflexia—a phenomenon that occurs when blood pressure rises
uncontrollably and cannot be corrected due to disruptions of descending
sympathetic pathways in the spinal cord. [88, 89]
The purpose of the current study was to ascertain a timeline for the
development and maintenance of SCI-induced polyuria, with a focus on
contributions of key targets not only in the kidney, but within the hypothalamus as
well. Neurons in the hypothalamus manufacture AVP in the supraoptic nucleus
(SON), paraventricular nucleus (PVN) and, the suprachiasmatic nucleus (SCN).
[90] Under normal physiological circumstances, AVP is released by the posterior
pituitary in response to hypotension, and/or an increase in extracellular
osmolarity. In the kidney, AVP activates V2R to increase AQP2 channels for the
reabsorption of solute-free water back into the bloodstream. An increase in blood
volume will trigger the release of ANP from the heart and within the kidney will
activate NPRA in order to increase the excretion of salt and inhibit the
reabsorption of water. [91, 92] Understanding the timeline of when these key
biomarkers are significantly altered post-injury will provide a therapeutic window
for intervention.
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Methods
Animals
All animal experiments and procedure protocols were reviewed and
approved by the University of Louisville Institutional Animal Use and Care
Committee (IACUC) and carried out in accordance with the National Institutes of
Health (NIH) guidelines. A total of 94 adult male Wistar rats were used for the
entirety of these experiments (Table 1). We have opted to utilize only adult male
rats for the current study since prevalence of SCI is predominantly male. Six
timeline SCI groups included study endpoints at 3, 7, 14, 28, 42, and 84 days
post-injury (dpi) as well as three surgical sham groups matched for endpoints 3,
14, and 42 dpi.

Spinal Cord Injury (SCI)
After baseline/pre-injury data was obtained (see below), animals were
anesthetized with an intraperitoneal injection of a mixture of ketamine (80 mg/kg,
Ketoset®; Fort Dodge Laboratories, Fort Dodge, IA) and xylazine (10mg/kg,
AnaSed; Lloyd Laboratories, Shenandoah, IA). Both toe-pinch and orbital
reflexes were monitored to assure a deep anesthetic plane was reached. The
surgical site was shaved and cleansed with Chlorhexidine scrub 4% (Henry
Schein) before placement on a heating pad and application of sterile ocular
lubricant (OptixCare, Aventix). A T8 laminectomy was performed to expose the
T9 spinal cord level. An Infinite Horizon (IH) impactor (Precision Systems and
Instrumentation LLC; Fairfax Station, VA) was used to administer a 215-kilodyne
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contusion with no dwell time at the T9 spinal level, which yields a moderatesevere extent of injury with white matter sparing averaging approximately 11%.
[2, 93] The muscular layer was then sutured with 4-0 surgical suture (Ethicon;
Somerville, NJ), and the skin closed with surgical wound clips. Surgical sham
animals underwent the same procedure, but no contusion injury was
administered. Both penicillin G (Penject; Henry Schein Animal Health, Dublin,
OH) and meloxicam (Eloxiject; Henry Schein Animal Health) were injected
subcutaneously per established post-operative care procedures. [35, 50, 94]
Physiological saline was also administered post-operatively (5mL before
contusion and 5mL after contusion). Bladder emptying via Crede maneuver was
performed three times daily until individual animals reached reflexive bladder
function (by 6 days [95, 96]). Residual volumes at 4 dpi were collected and
measured for use as indicator of lesion severity, per our previous study showing
peak amounts at this time point due to flaccid paralysis from spinal shock during
the earliest phase post-injury. [2] Note that the injury procedure is available for
online viewing in a published video journal from our lab. [50]

Metabolic Cage Data Collection
A six station Comprehensive Lab Animal Monitoring System (CLAMS;
Columbus Instruments, Columbus, OH) was used to monitor 24-hour urine output
volume and drink volume following established protocols. [2, 35, 97] Food and
water were available ad libitum. As part of the acclimation procedure of animals
to the CLAMS unit, pre-injury baseline data was collected twice in one week, but
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only the second 24-hour period was used for analysis. Metabolic cage
assessments were then carried out once weekly after SCI (number of times
variable between time-course groups). [7, 35, 50]

Blood Sample Collections
For serum samples, blood was collected via the lateral tail vein at preinjury and terminal time points following standard procedures. [7, 98] Animals
were anesthetized with isoflurane before shaving the base of the tail to better
visualize the lateral tail veins. Once the animals were placed on a heating pad,
an 18g needle was used to puncture either of the lateral tail veins. Between 0.50.7 mL of venous blood was then collected into serum separator tubes (BD
microcontainer, Becton, Dickinson and Co.). Light pressure was applied to the
puncture site with 2”x2” gauze until bleeding stopped. When necessary, wound
clotting was achieved using styptic powder with benzocaine (Kwik-Stop, ARC
Laboratories). The blood samples were centrifuged at 14,000 rpm for 15 minutes
and serum was collected and frozen at -20oC.

Locomotor Assessment
The Basso-Beattie-Bresnahan (BBB) open field locomotor test [99] was
performed weekly on each rat as well as the day prior to termination and
subsequent tissue removal. Each single score per animal represents an average
of the left and right hindlimb BBB score assigned by two experimenters blinded to
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time point status. This assessment is used as an additional indicator of lesion
severity and spontaneous recovery, per our previously published data. [2]

Tissue Collection and Histology
On the specified terminal date (3, 7, 14, 28, 42, 84 dpi/sham
laminectomy), animals were perfused transcardially with a solution of heparinized
saline (1mL heparin/100mL normal saline) followed by 4% paraformaldehyde.
Although multiple tissues were retrieved, only the brain, spinal cord (lesion site),
and the left kidney were removed and utilized in this study for
immunohistochemistry, contusion epicenter reconstruction, and Western Blot
analysis, respectively. Note that the kidney was retrieved prior to the 4%
paraformaldehyde perfusion for Western Blot assessments. Each kidney was cut
to ~0.1g sections (including both medulla and cortex) prior to storage at -80°C.
The brain and spinal cord were submerged in 4% paraformaldehyde and
stored for at least 24h at 4°C. Tissue was then moved to a 30% sucrose solution
and stored at 4°C until tissue has sunk to the bottom of the 15 mL conical tube
(24-48h) and stored until it was sectioned using a cryostat (Leica CM 1850).
Tissue was frozen in tissue freezing medium at -80°C to prevent freezing artifact.
Once ready to section, tissue was acclimated to -20°C inside the cryostat for at
least 30 min. Hypothalamus sections were collected at serial 25µm sections and
transferred to glass slides. Slides were then stored at 4°C until tissue was ready
to be stained.
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Immunohistochemistry was performed on tissue sections containing the
hypothalamus to visualize and quantify AVP-positive neurons. Fixed tissue was
washed in phosphate buffered saline (PBS) before unmasking epitopes using
antigen retrieval (IHC antigen retrieval reagent citrate, pH 6.0; Enzo Life
Sciences). After antigen retrieval, tissue sections were washed and blocked
(SuperBlock Blocking Buffer; ThermoFisher Scientific) before applying primary
antibodies. Tissue sections were incubated with primary antibody antivasopressin (1:1,000 dilution; ab39363, Abcam) overnight at 4°C. Slides were
then washed prior to incubation with fluorescent-conjugated goat anti-rabbit
secondary antibody (Alexa Fluor 488; ThermoFisher Scientific). Slides were
again washed before counterstaining with 4′,6-diamidino-2-phenylindole (DAPI)
to visualize nuclei.
To quantify the number of AVP-labeled neurons in the hypothalamus, the
SON, SCN, and PVN were targeted based upon regional landmarks identified in
the rat brain atlas. [100] A block of tissue from the collected brain was formed
rostral to the optic chiasm and rostral to the cerebellum. Once frozen, tissue
sections were cut at 25µm thickness and each slide stained contained three
tissue sections ≥75 µm apart to ensure cells were not counted more than once.
Slides were coded by an experimenter not directly involved in the study to blind
group identity. Using ImageJ (NIH), the area of the SON, SCN, or PVN was
outlined, and the number of AVP-positive cells with an intensity threshold at least
1.5 times above background level were counted to obtain the cells/area for
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quantification. At least four different sections of nuclei per animal were averaged
together for analyses.
The spinal lesion histology was carried out as previously described. [35,
97, 101] The spinal cord area containing the lesion (including ~2 levels above
and below) was sectioned at 20 µm thickness and stained with Luxol fast blue
and cresyl violet. The lesion epicenter and white matter sparing was captured
and analyzed using Spot Advanced software (Diagnostic Instruments, Sterline
Heights, MI) and Nikon E400 microscope. Spinal cord white mater was divided
into dorsal columns, dorsolateral funiculus, ventrolateral funiculus, and the
ventromedial funiculus, then separated into left and right sides. The percent white
matter sparing (WMS) was calculated by dividing the intact white matter at the
lesion epicenter by the average area of intact white matter present in more intact
sections both rostral and caudal the injury site. An average of two areas within 2
mm rostral and caudal was used for intact white matter. [102]

ELISA
Urinary ANP and creatinine was measured as previously described [35]
using an atrial natriuretic peptide Enzyme Immunoassay Kit (cat. No. K026-H1;
Arbor Assays; Ann Arbor, MI). Urine samples were diluted 1:5 for ANP, 1:20 for
creatinine and then plated in a 96-well plate in duplicate. Plates were read at
450nm OD using SoftMax Pro software (Molecular Devices). Urinary creatinine
was measured using DetectX Urinary Creatinine Detection Kit (cat. No. K002-H5;
Arbor Assays; Ann Arbor, MI). To control for differing urinary concentrations, the

31

urinary ANP levels were divided by urinary creatinine levels per ANP ELISA kit
instructions.
Baseline and terminal levels of serum AVP were determined using an
arginine vasopressin ELISA kit (cat. No. OKEH02585; Aviva Systems Biology).
Stored serum samples (see above) were diluted at 1:5 and ELISA was carried
out according to kit instructions.

Western Blot
Relative expression of AVP, NPR-A, AQP2, and ENaC (α, β, and γ
subunits) were analyzed by Western blot analysis according to our previously
published protocols. [7, 35] Kidney tissue was homogenized in ice-cold RIPA
buffer (Sigma, R0278) and protease inhibitor (78425, Thermo Scientific). The
concentration of protein was determined for each sample using Bradford protein
assay reagent (5000201, BioRad) and a spectrophotometer (at 595-nm
absorbance). Gels were then run by loading 50µg of protein per lane on a 4-15%
gradient gel (456-1085, mini protean TGX gels, BioRad) at 100 V for 80 minutes
in mini-protean gel tanks (running buffer was a 1X Tris-glycine-SDS buffer). The
protein was transferred to PVDF membranes for 2 hours in 4°C at 80V and
stained with Ponceau S. to visualize bands. The membranes were washed with
1X Tris-buffered saline with Tween 20 (TBST), then blocked in 5% non-fat dry
milk TBST solution for 1 hour. Membranes were then incubated in the primary
antibody at 4°C overnight. Antibodies used in this study included anti-NPRA
(Abcam ab154280, Cambridge, MA; dilution 1:1000), anti-AVPR V2 (Abcam
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ab108145, Cambridge, MA; dilution 1:750), anti-AQP2 (Abcam ab108065,
Cambridge, MA; dilution 1:1000), anti-ENaC α subunit (SPC-403 StressMarq
Biosciences; dilution 1:1000), anti-ENaC γ subunit (SPC-405, StressMarq
Biosciences; dilution 1:1000), anti-ENaC β subunit (14134-1-P, Proteintech;
dilution 1:750), and anti-β-actin (Sigma Aldrich #A5316, St. Louis, MO; dilution
1:5000). The membranes were washed three times with TBST prior to incubation
with HRP-conjugated secondary antibody in blocking solution for 2 hours at
1:3000. Lastly, the membranes were washed three times with TBST and
developed with ECL substrate before being imaged using BioRad Imaging
System and analyzed using ImageJ software (version 1.8, National Institute of
Health). Standardized values were obtained by normalizing experimental groups
to β-actin.

Statistical analysis
Both 24-hour urine and drink volumes from CLAMS data were exported
from Oxymax software to Microsoft Excel (Redmond, WA) for analysis. Each void
event recorded by the sensor of ≥0.2g within the 24-hour timeframe was
calculated for each animal. The total drink volume was recorded through the
CLAMS volumetric drink monitor. One-way repeated measures ANOVA analyses
were used across all SCI animal groups using SigmaStat v3.5 (Systat Software)
where significance was determined for p<0.05.
Data files for AVP, ANP and creatinine were exported from SoftMax Pro to
Microsoft Excel (Redmond, WA) for analysis. Samples and standards were
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averaged to create a standard curve to determine protein concentration. Due to
combined variability and sample size, terminal protein concentrations were
compared to their normalized baseline level for statistical analysis. Signed-ranks
tests were used to compare normalized baseline to terminal protein
concentrations where p<0.05 was considered statistical significance. A two-way
ANOVA was used for Western blot analysis to determine statistically significant
interactions between antibodies used and terminal time points. Values were
considered significant if p<0.05.
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Results
Nine animal groups in total consisted of six post-SCI recovery time points
(3, 7, 14, 28, 42, and 84 dpi) and three post-sham laminectomy time points (3,
14, and 42 dpi). Prior to contusion injuries, pre-injury baseline data was collected
including: 24-hour urine output and collection/drink volume, blood draws, and
BBB assessments. All animals scored 19 or above on the BBB scale indicating
that there were no prior or pre-existing motor deficits. Post-hoc analyses were
carried out between the six SCI groups and revealed no significant differences
for injury parameters (force, displacement), or 4-dpi residual urine volume
emptied by Credé (Table 1). However, there were significant differences among
BBB scores where both the 3 and 7 dpi animal groups received significantly
lower scores at terminal time points compared to the 14, 28, 42, and 84 dpi
animals (p<0.05), a finding consistent with the timing of previous locomotor
outcome data showing some limited recovery during the first two weeks postcontusion. [2]

24-hour Urine Volume
Both urine production and drink volume were measured weekly across 24hours to determine presence/absence of SCI-induced polyuria. Prior to contusion
injuries, each animal’s baseline was recorded as a further control (in addition to
sham groups) for each time point group. SCI-induced polyuria was present in all
SCI animal groups except for 3 dpi (Figure 5). By 7 dpi, each animal group had a
statistically significant increase in 24-h urine volume (p<0.05). Neither of the time

35

point groups after 3 dpi (7, 14, 28, 42, 84 dpi) were significantly different from
each other in urine output. Despite the significant increase in urine production
among all SCI animal groups apart from 3 dpi, there were no significant
increases in drink volume across any of the groups, a finding consistent with
previous studies. [2, 7, 35]

ELISA for Urinary ANP and Serum AVP
The importance of ANP in water balance, specifically in relation to
cardiovascular changes, is well established. [103-105] Thus, ELISA was used to
determine when and if alterations in urinary ANP occurred after SCI as previously
reported, [7, 35] using urine samples from the 24-h metabolic cage assessments.
Urinary ANP levels were found to be significantly increased at both 14 dpi and 42
dpi relative to baseline levels (Figure 6). Because blood pressure and water
balance are heavily affected by circulating AVP, ELISA was also performed to
obtain serum concentrations of AVP at pre-injury and terminal time points. Serum
AVP levels were significantly lower at two of the chronic time points relative to
pre-injury baseline concentrations (Figure 6).

Western Blot of Kidney Tissues
Western Blot analysis was performed on kidney tissue from six randomly
selected animals per group to visualize relative expression density of NPRA,
V2R, AQP2, and ENaC (α, β, and γ subunits) (Figure 7). For analysis of the time
point factor overall (regardless of receptor or channel), both sham and 3dpi were
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significantly different from all other time points, except for the 84 dpi group which
differed from 3 dpi but not shams. Relative expression of kidney V2R was
significantly decreased by 7 dpi and remained depressed at each subsequent
time point except for 84 dpi. The same pattern occurred for kidney AQP2
expression, which is directly related to V2R expression. For both V2R and AQP2,
7 dpi was significantly lower than several of the later time points. In contrast, the
density of NPRA expression was significantly higher at 3, 7, and 42 dpi relative to
only 14 dpi. In addition, since the α, β, and γ subunits form together to make
ENaC, Western blot analysis was done on all three. Although the density of
ENaC α expression was unchanged at all time points compared to time pointmatched sham groups, both ENaC β and γ expression densities were decreased
after SCI at several time points, beginning at 7 dpi. All pairwise multiple
comparison procedures (Bonferroni t-test) revealed a significant effect for only
the ENaC α subunit relative to the other 5 antibodies (p<0.001), reflecting the
lack of a time point effect for relative expression of ENaC α.

AVP labeling in hypothalamus
The number of AVP-positive cells in the SON was examined in all groups
and the only difference found was for the 14 dpi time point which were
significantly fewer relative to shams (Figure 8). Although the SON was the main
target of this study, both PVN and SCN neurons that were present within the
same tissue slices were examined as well. However, due to their relative size
and location relative to the SON, the overall cellular sample size was smaller.
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Within the PVN, there were no significant decreases in observed AVP-positive
cells at any time points compared to sham animals (data not shown). However,
the average AVP-positive cells/area within the SCN were significantly decreased
at 14 dpi and remained that way at all later time points (Figure 9).

White matter sparing
White matter sparing (WMS), an indicator of injury severity, was quantified
for all SCI animal groups. As shown in Figure 10, the WMS for both 3 and 7 dpi
were not different from each other. There was a statistically significant decrease
in WMS at the 14 dpi time point and beyond compared to both 3 and 7 dpi. Also,
WMS was further decreased by the 84 dpi time point, indicating continued
progression of damage at the lesion epicenter beyond 6 weeks post-contusion.
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Discussion
SCI-induced polyuria has been established as a major systemic issue that
arises after SCI in both human and pre-clinical animal SCI models. [1, 2, 106]
Previous data from our lab has shown that several key hormones and receptors
including AVP, ANP, V2R, and NPRA are associated with mechanisms
underlying SCI-induced polyuria. [7, 35] The current data reveal the timing of
these changes within the kidney itself with some additional contribution by AVPpositive neurons in the hypothalamus. Together, the current results illustrate both
peripheral and supra-spinal effects within one of many internal organ systems
post-SCI and demonstrates the impact of disrupting the body’s homeostatic
mechanisms on functional outcome and ultimately quality of daily living.
The animals in the current study presented with polyuria by 7 dpi and
lasted through the longest time point examined (84 dpi). This result differs from
the emergence of deficits in locomotor function, which appear immediately due to
initial spinal shock, but then partially recovers and plateaus after several weeks
at a level that is known to correlate with the extent of injury [107, 108] (and as
shown by the BBB scores in Table 1). The fact that polyuria onset is slightly
delayed and maintains at a steady state despite continued progression of
damage at the lesion epicenter (re WMS data), indicates that the underlying
mechanisms are secondary to damage of the spinal cord itself. Noteworthy is
that this increase in urine volume was not matched with an increase in drink
volume, which likely means the rats were under-hydrated, but typical signs of
dehydration were not present (skin turgidity, reduced urine volume, urine color
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change reflecting higher concentration, porphyrin staining of the eyes and nose)
as they were visually inspected and tended to daily. One important question
surrounding polyuria involves the source of the additional urine being voided.
Previous experiments investigating fecal water weight resulted in a difference in
acute, but not chronic time points, suggesting water does not come from any
changes in water content within the feces. [2] Serum osmolality was also
previously tested and found to be significantly increased after SCI. [7] Increased
osmolality was in the direction that should stimulate the release of more AVP,
which does not occur, indicating an overall disruption of homeostatic
mechanisms. Although animals may be under-hydrated, physical dehydration is
unlikely the cause for SCI-induced polyuria, as many SCI patients purposefully
restrict fluids to avoid nighttime catheterizations.
Urinary ANP and serum AVP levels for the various SCI animal time point
groups were significantly altered in the direction that would produce polyuria at
various 14 to 42 dpi time points, but did not match the onset (7 dpi) and duration
of the overproduction of urine that was measured. These findings signify that
changes in serum levels of ANP and AVP are variable and not static, which
implicates other important factors such as corticosterone (increased urinary
levels previously shown at 14 dpi) and/or key receptors/channels (V2R, NPRA,
AQP2, and ENaC) in the kidney (altered levels previously shown at 70 dpi time
point). [7, 35] Although AVP and ANP are key regulators of water and solute
balance and likely play a major role in SCI-induced polyuria, they are not the only
factors involved in urine production. The result that the significant alterations do
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not match up with chronic polyuria is indicative that other mechanisms and
biomarkers are involved.
In the current study, Western blot analysis of fresh kidney tissue at each
time point after SCI revealed significant changes at many post-SCI but not sham
laminectomy or 3 dpi time points for one or more of the receptors/channels
examined. Both V2R and AQP2, which work together, were significantly
decreased starting at 7 dpi but reverted to sham levels by 84 dpi. Since polyuria
is still present at this time point, it is likely that these levels reflect constant
variability within the homeostatic water balance system rather than recovery to
baseline levels. Later time points beyond 84 dpi would be necessary to address
this possibility.
For NPRA, significant changes were present in several time points relative
to 14 dpi, but not sham and 3 dpi groups. The timing of the fluctuations, when
considered with the ANP ELISA data, indicates that different compensatory
mechanisms may be at play. The fluctuations of NPRA levels and ANP post-SCI
could reflect its functional role on two different systems. NPRA levels could be a
response to low blood volume that is often seen after SCI and/or due to
disruption of urinary regulations. [109-112] Increased NPRA has been shown to
be associated with the down-regulation of ANP. [85] SCI often results in
hypotension, which may result in an increase in NPRA causing a significant
decrease in blood pressure. [111] Low levels of ANP is associated with
hypertension, and the inverse is true that an increase in ANP leads to
hypotension. [113] Further research will be needed to better understand these
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multi-system effects. Note that previously, these receptors/channels were shown
to be positively impacted with activity-based recovery training. [35] However,
training benefits multiple locomotor and non-locomotor systems, including
functions of both the urinary tract and cardiovascular system. [4, 35, 101, 114,
115]
There was no variation in the relative density of the ENaC α subunit after
SCI, whereas both ENaC β and γ were significantly decreased at several time
points. Differences in the kidney expression levels of the various ENaC subunits
post-SCI remains unclear. ENaC α is critical for ENaC pore formation, as it has
the ability to form a functional channel on its own, whereas ENaC β and γ are
responsible for membrane surface expression (functionality). [116] Channels
formed only with the α subunit form less functional channels than with all three
subunits together. Further, the β and γ subunits are more molecularly similar,
making it clear there is a distinct difference between the β/γ versus α subunit.
[117] Note that studies investigating the distinction between the β and γ subunit
concluded that the γ is more important than the β subunit for cell membrane
surface trafficking and expression, thus overall channel functionality. [118, 119]
Previously we found that both AVP and ANP, in addition to kidney V2R,
NPRA, AQP2, and ENaC levels, were altered two weeks post-SCI and were
significantly altered at 10 weeks. Interestingly, findings throughout this study
include these same fluctuations in both AVP/ANP as well as several of the
receptors, but several of the time points in between revert to sham levels. These
results suggest that the system may be constantly trying to correct itself (as seen
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by “normal” levels of AVP/ANP and receptor densities). However, polyuria is
present at every time point starting at 7 dpi which further suggests that water
balance homeostasis is never fully achieved after SCI and there are likely
multiple systems involved, including others not examined here such as the renin
angiotensin aldosterone system (RAAS) and/or corticosterone levels. [120] The
RAAS is essential for fluid balance and cardiovascular health (i.e. blood pressure
regulation) which are commonly impacted by SCI. [121, 122] The extent of how
RASS is affected by SCI is currently unknown, and therefore should be examined
further in future studies. [123] Note that the ENaC is regulated by aldosterone,
[124, 125] a critical part of RAAS, [120] and both the ENaC β and γ subunits in
kidney significantly decreased after SCI.
To further identify possible mechanisms contributing to SCI-induced AVP
dysfunction, the density of AVP-positive cells in SON, SCN, and PVN of the
hypothalamus was examined. The critical role of AVP in controlling water/salt
balance is well-established. AVP is also known to escalate inflammation which
further contributes to neuronal disruptions after traumatic brain injury, in addition
to its association with SCI-induced polyuria. [7, 35] While SON analysis revealed
a significant decrease in AVP-labeled cells at 14 dpi, there were no other time
points that demonstrated significant differences compared to surgical sham
animals. Previously, a decrease in serum AVP was found as early as two weeks
post-contusion, whereas this study found significant decrease in AVP at 28 and
42 dpi, with a recovery at 84 dpi. However, Western blot analysis revealed that
kidney V2R levels were decreased as early as 7 dpi. This finding suggests that
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there is a significant change in V2R regardless of serum AVP levels, and further
reveals the instability of this system after SCI. Under normal physiological
conditions, the sympathetic nervous system works together with neuroendocrine
and hormonal control in both central and peripheral homeostatic mechanisms.
After SCI, this balance is disrupted and causes a cascade of dysfunction that
involves hormonal and neuroendocrine changes which subsequently lead to
physical symptoms such as orthostatic hypotension and SCI-induced polyuria, to
name a couple.
In contrast to the SON, the number of AVP-labeled cells in the SCN was
significantly lower in all SCI animal groups starting at 14 dpi. The SCN is closely
tied with circadian control, which is very important for AVP release. [126] Recent
studies have shown significant disruptions of circadian rhythmicity post-SCI,
including activity, body temperature, clock gene expression, and corticosterone
production. [127, 128] Clock genes, which are in part responsible for many
biological functions such as sleep/wake cycles, the autonomic nervous system,
body temperature, and gastrointestinal motility, [129-131] are also functions
regulated by the SCN and are all disrupted post-SCI. [132-134] The contribution
of SCN to SCI-induced polyuria likely relates to the diurnal variation of AVP
production, as clinical studies have identified the loss of this pattern as being
responsible for the emergence of nocturia after SCI. [1, 82, 135]
For the PVN, no significant differences in AVP-labeled cells were found
post-SCI. Note that the entire PVN was not examined and based upon its
location relative to the SON, fewer areas were analyzed, which reduces the
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possibility of finding any differences that may exist. The PVN is only one of three
regions where AVP is produced [90], and to a lesser extent than the SON, [136]
but a full analysis of the entire region should be done in future experiments to
determine definitively if SCI impacts this area of the hypothalamus. As the data
taken from the PVN analysis is limited, it is pilot in nature and further studies are
needed to make any conclusions. However, an increase in animals and PVN cell
counts will likely not yield significant results as the SON yielded a significant
decrease in AVP-positive cells at only one time point.
Taken together, the results from this study provide further evidence that
SCI is a complex and progressive injury, which includes changes in various
metabolic peptides (AVP, ANP, V2R, NPRA, ENaC) that contribute to the
development and maintenance of SCI-induced polyuria. One study limitation is
that the RAAS system was not examined. As mentioned above, RAAS plays a
major role in homeostatic fluid balance and should be a target for future studies,
not only for SCI-induced polyuria, but for cardiovascular health as well. Future
studies that target individual elements alone or in combination including RAAS
may elucidate each of their contributions toward SCI-induced polyuria and help
identify potential therapeutic targets beyond desmopressin, which has limited
efficacy (such as hyponatremia [87] and restricted use on patients ≥65 years of
age [137]) and is likely, as the current data suggest, not the only contributing
factor related to SCI-induced polyuria.
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Table 1
SCI Impactor Parameters and Assessment Outcome Values
Group

n

Injury force (kdyne)

Displacement (μm)

4-day urine

7 dpi BBB

Terminal
BBB

Sham

28^

-

-

0

20.1 ± 0.74

19.8 ± 0.83

3 dpi

12

223.4 ± 15.2

1367.4 ± 124.5

-

-

4.3 ± 2.63*

7 dpi

10

244.4 ± 34.5

1330.8 ± 311.7

3.95 ± 0.66

6.00 ± 0.78

6.0 ± 0.78*

14 dpi

11

222.7 ± 3.8

1378.5 ± 134.1

3.31 ± 1.07

7.6 ± 0.20

8.4 ± 1.57

28 dpi

11

224.3 ± 13.7

1427.8 ± 139.1

3.5 ± 1.07

7.4 ± 2.25

9.6 ± 1.57

42 dpi

10

238.5 ± 33.3

1501.7 ± 79.8

1.86 ± 1.16

5.2 ± 2.93

9.4 ± 1.35

84 dpi

12

237.3 ± 35.3

1494.4 ± 162.3

4.25 ± 1.11

6.4 ± 2.43

9.9 ± 1.24

Values indicated are mean ± standard deviation; all SCI groups are significantly
different (p<0.01) from sham (4-day urine, 7 dpi and terminal BBB).
^ Data collected from 3 sham animal groups were combined as no significant
differences were found.
* Both the 3 and 7 dpi injured groups received significantly lower scores than 14,
28, 42, and 84 dpi groups (p<0.05).
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Figure 5:
Metabolic Cage Data Summary. Total 24-hour urine volume output (left plot)
indicates a statistically significantly increase at the 7, 14, 28, 42, and 84 dpi time
points but not at 3-dpi relative to their pre-injury baseline and shams. Total 24hour drink volume (right plot) indicates the absence of any statistically significant
differences over time relative to pre-injury levels as well as shams. Values are
represented as means with standard error of means (SEM) bars included
(*p<0.05). Data collected from 3 sham animal groups were combined as no
significant differences were found (solid horizontal line represents pre-injury time
point; dotted line post-injury terminal time point).
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Figure 6:
Urinary ANP and serum AVP. Both urinary ANP and serum AVP levels were
normalized to their pre-injury baseline concentrations. At 14 dpi and 42 dpi, the
urinary ANP/creatinine levels were significantly increased compared to pre-injury
baseline levels. However, sham, 3, 7, or 84 dpi groups did not demonstrate any
statistically significant changes in urinary ANP/creatinine levels. Serum AVP
concentrations were significantly decreased at 28 dpi and 42 dpi, but not 84 dpi.
Error bars represent SEM *significant different from pre-injury baseline, p<0.05.
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Figure 7:
Kidney tissue Western blot summary of results. As shown graphically in (A),
relative expression of vasopressin 2 receptor (V2R), aquaporin 2 channel (AQP2)
densities and epithelial sodium channels (ENaC β and γ subunits) from kidney
tissue were significantly depressed at various time points compared to surgical
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sham animals, as well as 3 dpi (*). In contrast, the relative expression of
natriuretic peptide receptor A (NPRA) in the kidney was significantly lower at 14
dpi compared to 3, 7, and 42 dpi (#). Representative examples of Western blots
showing expression levels is provided in (B) for V2R and NPRA.
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Figure 8:
The supraoptic nucleus (SON). A representative section showing AVP-labeled
cells in SON at each time point group is provided in (A), including a higher
magnification of the sham group example for visualization of labelled (arrow) and
non-labelled (arrowhead) cells. In (B), a modified plate from the Rat Brain Atlas
illustrates the location of the SON within the hypothalamus.29 The average
number of AVP-labeled cells per area in SON for each time point group is
presented graphically in (C). The only time point after SCI that demonstrated a
statistically significant different number of AVP-positive cells in the SON
compared to the sham group was at 14 dpi (*p<0.05, error bars represent SEM).
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SON: sham (n=9), 3 dpi (n=7), 7 dpi (n=7), 14 dpi (n=8), 28 dpi (n=6), 42 dpi
(n=7), 84 dpi (n=6).

52

Figure 9:
The suprachiasmatic nucleus (SCN). A representative section showing AVPlabeled cells in SCN at each time point group is provided in (A), including a
higher magnification of the sham group example for visualization of labelled
(arrow) cells. In (B), a modified plate from the Rat Brain Atlas illustrates the
location of the SCN within the hypothalamus.29 The average number of AVP+
cells/μm in the SCN (shown in (C)) are significantly decreased at the 14, 28, 42,
and 84 dpi time points, but not at 3 or 7 dpi (*p<0.05, error bars represent SEM).
SCN: sham (n=3), 3 dpi (n=4), 7 dpi (n=3), 14 dpi (n=4), 28 dpi (n=3), 42 dpi
(n=3), 84 dpi (n=5).
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Figure 10:
White Matter Sparing. A significant decrease in white matter sparing (WMS)
occurred from the 14 dpi time point onward. At 84 dpi, there was a further
significant decrease in WMS relative to 42 dpi (* versus 3 and 7 dpi, p<0.05; **
versus 42 dpi, p<0.05). Bars represent means and error bars represent SEM.
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CHAPTER III
EFFECT OF T3 SPINAL CONTUSION INJURY ON UPPER URINARY TRACT
FUNCTION

Introduction
Spinal cord injury (SCI) is a progressive injury that significantly impacts
multiple systems affecting quality of life, including motor, respiratory,
cardiovascular, gastrointestinal, and bladder/urinary tract functions. [80, 110,
138-140] The presence of SCI-induced polyuria increases the number of
catheterizations, especially at night (disrupting sleep), which raises the risk of
developing genitourinary infections, a leading cause for hospitalizations in the
SCI population. [141] SCI-induced polyuria has shown to be present in both the
pre-clinical SCI animal model and clinically, [2, 35, 36, 142] regardless of severity
[2] or completeness [143] of injury.
Under normal physiological conditions, systemic arginine vasopressin
(AVP) and blood pressure decreases at nighttime, slowing the production of urine
and allowing for uninterrupted sleep. Previous clinical findings have reported a
significant lack in diurnal variation (fluctuations between day and night) for urine
output and serum AVP levels in the SCI population. [144] Production of AVP
occurs within the supraoptic nucleus (SON), paraventricular nucleus (PVN), and
suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN, which is a main
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regulator of circadian control, including the sleep/wake cycles, was recently
shown in a T9-level contusion rat model to contain significantly fewer AVPlabelled cells beginning as early as 14 days post-injury (dpi). [145] However,
significant up or down regulation at various time points, beginning at 7 days post
injury, have been shown for kidney natriuretic peptide receptor-A (NPRA), kidney
vasopressin-2 receptor (V2R), kidney aquaporin-2 channels (AQP2) and kidney
epithelial sodium channels (ENaC, β and γ but not α subunits), suggesting both
central and peripheral mechanisms are involved in the development and
maintenance of polyuria. [7, 35, 145]
Autonomic dysregulation occurs after SCI due to disruption of supraspinal
sympathetic pathways descending from various brain regions and/or local spinal
networks and/or pre-ganglionic sympathetic outputs. The kidneys, which regulate
and balance the body’s water and metabolite content (filtration from blood as
urine), receives sensory innervation from T9-L2 ipsilateral dorsal root ganglia and
sympathetic supply from post-ganglionic neurons located within the celiac
ganglion, [146] which has been traced to pre-ganglionic neurons at T4-T13 spinal
levels. [147] Note that there is limited evidence for specific parasympathetic
supply to the kidneys. [148, 149] Sympathetic preganglionic fibers receive input
from both intraspinal and supraspinal neurons. [150] The descending supraspinal
inputs to sympathetic preganglionic neurons arise from the rostral ventrolateral
medulla, rostral ventromedial medulla, caudal raphe nuclei, the A5 region, and
the paraventricular nucleus of the hypothalamus. [151, 152] Subsequent to the
loss of supraspinal drive post-SCI, spinal autonomic interneurons undergo
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plasticity and are key regulators of spinal sympathetic preganglionic circuitry.
[153] Note also that the vagal supply of the viscera has been shown to undergo
neurochemical plasticity post-SCI, a finding with implications for visceral
homeostatic mechanisms and nociceptive signaling following chronic injury. [154]
Our pre-clinical research on SCI-induced polyuria to date has focused on
a T9 level injury, [2, 35, 142] which disrupts both supraspinal and local
preganglionic/interneuronal sympathetic spinal circuitries to the kidney and
surrounding vasculature. The goal of the current investigation was to determine if
loss of supraspinal sympathetic control to the kidney and/or disruption of local
spinal circuitry surrounding a T9 level SCI mediate the development and
maintenance of polyuria by examining outcomes after a T3-level spinal
contusion, which is just above the sensory/interneuron/preganglionic supply
to/from the kidneys. Of potential relevance are findings showing that cervical
(C2-C8) level SCI in individuals generate higher urinary outputs than those
having T1-L1 level injuries, specifically at night [36] in addition to being at greater
risk for autonomic dysreflexia. [88]
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Methods
Animals
All animal experimental procedures and protocols were reviewed and
approved by the Institutional Animal Use and Care Committee (IACUC) at the
University of Louisville School of Medicine and carried out according to National
Institutes of Health (NIH) guidelines. For this study, 18 adult male Wistar rats
(~250 g) were individually housed with a 12:12 light-dark cycle. Animals either
received a T3 SCI (n=12) or sham surgery (laminectomy with no injury, n=6).

Spinal Cord Injury (SCI)
Following pre-injury baseline assessments (see below), animals were
anesthetized with intraperitoneal injection of ketamine (80 mg/kg, Ketoset®; Fort
Dodge Laboratories, Fort Dodge, IA) and xylazine (10mg/kg, AnaSed; Lloyd
Laboratories, Shenandoah, IA). To assure a deep anesthetic plane, both toe
pinch and orbital reflexes were monitored. The surgical area was shaved and
cleansed with 4% chlorhexidine scrub (Henry Schein) and sterile ocular lubricant
(OptixCare, Aventix) applied. A T2 laminectomy was performed to expose the T3
level of spinal cord. Contusions were produced at T3 using an Infinite Horizon
(IH) impactor (Precision Systems and Instrumentation LLC; Fairfax Station, VA)
per established T9 protocols (215-kilodyne force with no dwell time). [2, 155] The
muscular layer and skin were closed with 4-0 surgical suture (Ethicon;
Somerville, NJ), and surgical wound clips. Antibiotic (penicillin G, PenJect; Henry
Schein Animal Health, Dublin, OH) and analgesic (meloxicam, Eloxiject; Henry
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Schein Animal Health) were injected subcutaneously per established postoperative care procedures (0.1 mL, and 0.2 mL/animal, respectively). [35, 50, 94]
Physiological saline was also administered at 5mL before contusion and 5mL
after contusion. Manual bladder emptying was performed via Crede maneuver
three times daily until individual animals reached reflexive bladder function (by 6
dpi [95, 96]). This procedure from our lab is available in video journal format
online. [50]

Metabolic Cage Data Collection
For 24-hour metabolic cage data collection, animals were placed in a six
station Comprehensive Lab Animal Monitoring System (CLAMS; Columbus
Instruments, Columbus, OH) to monitor 24-hour urine output volume and drink
volume according to established protocols. [2, 35, 97] To acclimate animals to
the CLAMS unit, pre-injury baseline data was collected twice in one week, but
only the second 24-hour period was used for analysis. Metabolic cage
assessments were then carried out once weekly. [7, 35, 50] Calculation of 24hour urine volumes was obtained by taking the sum of each void event ≥0.2g
recorded by the sensor within the 24-hour timeframe. The total drink volume was
recorded through the CLAMS volumetric drink monitor.

Blood and Urine Sample Collection
The lateral tail vein was used for blood/serum sample collection at preinjury and end of the study (six weeks post-injury (wpi)) time points. Isoflurane
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was used to anesthetize the animals. The base of the tail was shaved for better
visualization of lateral tail veins. Animals were then placed on a heating pad
where an 18g needle was used to puncture either of the lateral tail veins, and
0.5-0.7 mL of blood was collected into serum separator tubes (BD
microcontainer, Becton, Dickinson and Co.). Bleeding was stopped by applying
light pressure with 2”x2” gauze, or when necessary styptic powder with
benzocaine (Kwik-Stop, ARC Laboratories). Blood samples were then
centrifuged at 14,000 rpm for 15 minutes and the serum was collected and stored
at -20oC for future analysis. Urine samples were collected from 24-hour metabolic
cages. Urine samples were then centrifuged at 14,000 rpm for 15 minutes. The
urine was aliquoted into 2mL tubes and stored at -20oC until used for analysis.

Locomotor Assessment
For locomotor assessment, the Basso-Beattie-Bresnahan (BBB) open field
locomotor test [99] was performed weekly on each rat as well as the day prior to
terminal time point. A single score per animal was obtained by averaging the left
and right hindlimb BBB score assigned by two experimenters blinded to time
point status. These scores are used as an additional indicator of lesion severity
and spontaneous recovery, per our previously published data, where taken
together with white matter sparing (WMS) can identify injury outliers. [2]

Tissue Collection and Histology
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Animals underwent transcardial perfusions with heparinized saline (1mL
heparin/100mL normal saline) followed by 4% paraformaldehyde at the end of
the study (6 wpi). Multiple tissues were removed, but only the brain (for
hypothalamus) and the spinal cord (lesion site) were used for this study. The
brain and spinal cord were then submerged in 4% paraformaldehyde for storage
at 4°C for at least 24 hours, then moved to a 30% sucrose solution and stored at
4°C until it was sectioned using a cryostat (Leica CM 1850).
For hypothalamus tissue, serial sections of 25 µm were cut, assuring that
each glass slide contains three sections of ≥75 µm apart to avoid double
counting of cells to be stained for analysis. Tissue was stained with anti-AVP
primary antibody (ab39363, Abcam) to visualize and quantify the number of AVPlabelled cells in the SCN, a region involved in the diurnal variation of AVP. [156]
Slides were washed in 1X phosphate buffered saline before and after antigen
retrieval (Enzo Life Sciences), then incubated in 0.3% H2O2 for peroxide
blocking. Blocking was performed using SuperBlock (Thermo Scientific) and
primary antibody was diluted at 1:1000 in 4% normal goat serum, applied to
slides, and incubated at 4°C overnight. Secondary antibody (fluorescentconjugated goat anti-rabbit; Alexa Fluor 488, ThermoFisher Scientific) was
diluted in 4% normal goat serum and incubated for 1 hour at room temperature.
Slides were washed, incubated with 4′,6-diamidino-2-phenylindole (DAPI,
Thermo Scientific), then cover slipped before imaging and analysis. The number
of AVP-positive cells was quantified using ImageJ (NIH). First, the area of the
SCN was outlined, and AVP-labelled cells with an intensity threshold at least 1.5
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times above background level were counted to obtain the cells/area for
quantification. At least four different sections of nuclei per animal were averaged
together for analyses, per our published protocols. [145]
Histology of the spinal lesion site for WMS was carried out as previously
described. [35, 97, 101] The spinal cord lesion site, including ~2 levels above and
below, was sectioned at 20 µm thickness and stained with Luxol fast blue and
cresyl violet. The lesion epicenter and WMS was captured and analyzed using
Spot Advanced software (Diagnostic Instruments, Sterline Heights, MI) and
Nikon E400 microscope. The percent WMS was calculated by dividing the intact
white matter at the lesion epicenter by intact white matter rostral and caudal the
injury site. An average of two areas ≥2 mm both rostral and caudal was used for
intact white matter.

ELISA
Urinary atrial natriuretic peptide (ANP) was measured using an Enzyme
Immunoassay Kit (cat. No. K026-H1; Arbor Assays; Ann Arbor, MI) and
creatinine was measured using DetectX Urinary Creatinine Detection Kit (cat. No.
K002-H5; Arbor Assays; Ann Arbor, MI) for pre-injury and 6 wpi time points. [35]
Urine samples were diluted at 1:5 for ANP and 1:20 for creatinine, and then
plated in a 96-well plate in duplicate. ANP and creatinine plates were read at
450nm OD using SoftMax Pro software (Molecular Devices). Urinary creatinine
levels were used to control for differing urine concentrations per ANP ELISA kit
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instructions. To obtain accurate urinary ANP levels, the ANP levels were divided
by the creatinine levels.
Baseline and terminal levels of serum AVP were determined using an
arginine vasopressin ELISA kit (cat. No. OKEH02585; Aviva Systems Biology).
Stored serum samples (see above) were diluted at 1:5 and ELISA was carried
out according to kit instructions.

Statistical analysis
Two-way ANOVA analyses were performed to compare T3 to sham
animals for metabolic cage, ELISA, and AVP-labelled cell count data using
SigmaStat v3.5 (Systat Software) where significance was determined for p<0.05.
For ELISA analysis, the data files for AVP, ANP and creatinine were
exported from SoftMax Pro to Microsoft Excel (Redmond, WA). Averages of
samples and standards were used to create a standard curve for the
determination of protein concentration. Due to combined variability and sample
size, terminal protein concentrations were compared to their normalized baseline
level for statistical analysis. Signed-ranks tests were used to compare normalized
baseline to terminal protein concentrations where p<0.05 was considered
statistical significance.
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Results
Data was obtained from a total of 17 adult male Wistar rats (T3 SCI n=11;
surgical sham n=6; one animal died due to complications of injury). Prior to
contusion injuries, pre-injury baseline data was collected, which included 24-hour
metabolic cages, blood draws, and BBB assessments. The mean force and
displacement was 218.8 ± 7.5 (standard deviation) kdyne and 1310.6 ± 175 μm,
respectively. The 4-day residual volume (measured on day 4 post-injury using
Crede) was 0.35 ± 0.21 mL. The 7 days post-injury (dpi) and 6 wpi BBB scores
were 8.80 ± 1.6 and 11.0 ± 0, respectively. The 7 dpi and 6 wpi BBB scores for
the surgical sham group was 20.0 ± 0 and 20.3 ± 0.82, respectively. Post-hoc
analyses for outliers (Grubbs’ Test) were done and none were found in either
animal group.

24-hour Urine and Drink Volumes
To determine the presence of SCI-induced polyuria, metabolic cages were
used to quantify 24-hour urine volumes. The data are presented in Figure 11.
Compared to both sham and pre-injury baseline volumes, T3 animals revealed a
statistically significant increase in 24-hour urine volumes starting at 1 wpi and
was present at every other time point. Drink volumes were not significantly
different between the T3 SCI animals and shams at any time point, nor were any
time points statistically significantly different from each other.

ANP and AVP
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Both urinary ANP and serum AVP were investigated using ELISA, as they
are key regulators of cardiovascular and water/solute homeostasis. Serum levels
of AVP were significantly lower in T3 SCI animals compared to normalized
baseline levels at 6 weeks post injury (0.62 ± 0.08 fold change). Additionally,
urinary ANP was significantly elevated (average 1.62 ± 0.07 fold change) at 6 wpi
compared to baseline in T3 SCI animals.

AVP labeling in hypothalamus
The number of AVP producing cells in the SCN was quantified and
revealed that the average AVP-positive cells/µm was significantly lower in the T3
SCI animals than the T3 shams (Figure 12). Note the integrity of the
hypothalamus tissue was not ideal for quantification in several of the animals,
yielding n=5 for T3 SCI and n=4 for T3 sham groups. It is important to note that
tissue collection from all animals occurred within the same two-hour timeframe,
as AVP production in the SCN is time dependent. [157]

White Matter Sparing
The mean percent WMS for the T3 SCI group was 21.2% ± 1.7%. As a
further analysis, a Pearson correlation was conducted on WMS and terminal (6
wpi) 24-hour urine volumes. There was no significant correlation between WMS
and 24-hour urine volume (r=0.34; p>0.05).
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Discussion
The results of the current T3-level contusion SCI study demonstrate a
significant increase in 24-hour urine volumes at 1 through 6 wpi. Since the spinal
sympathetic supply to the kidney is mostly intact below a T3 level of injury, the
development and maintenance of SCI-induced polyuria is likely due to loss of
descending supraspinal circuitries, which likely disrupts fluid and metabolite
homeostasis precipitating plasticity within the kidney itself (such as previously
seen with fluctuations in the relative expression of receptors and channels[7, 35,
145] as well as central regions including those containing AVP-producing
neurons within the hypothalamus. [145] Notably, the daily urine volumes in the
T3 SCI animals was equivalent to T9 SCI animals of prior studies. [35, 145]
Further, similar to previous findings with a T9 SCI, there were no significant
changes in drink volumes at any of the time points. [2, 35] The stability in drink
volume from pre-SCI through chronic SCI, taken together with an increase in
urine production/passage, is indicative of the extent to which systemic body
water/solute balance is severely disrupted after SCI. Further studies investigating
sources of this disbalance are in progress.
Also consistent with prior findings in T9 contused rats was a decrease in
serum AVP and an increase in urinary ANP after chronic T3 SCI. [35, 142] Both
ANP and AVP are crucial for body water/solute homeostasis, and the change of
their alteration observed in this and recent studies are in the direction that would
result in polyuria. [35, 158] The similar findings with T3 SCI animals in relation to
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T9 SCI animals previously reported [35, 145] suggest that these mechanisms are
present regardless of level of injury.
An additional focus of this study was the SCN of the hypothalamus, as
previous data from our lab suggests there are no consistent changes in numbers
of AVP-labeled cells within the SON or PVN after chronic T9 SCI and clinically,
diurnal variations of AVP are lost. As seen with T9 lesions, there were
significantly fewer AVP-labeled cells in the SCN of the hypothalamus in T3 SCI
rats. [145] The SCN is one of three nuclei in the hypothalamus where AVP is
made, [159] and is heavily involved in circadian control of both humans and
rodents. [160, 161] Recent studies have reported that circadian rhythmicity is
significantly disrupted by SCI. [127, 144, 162] However, we have previously
shown with a T9 level injury that significant polyuria is present in both the
quiescent and active phase of the light-dark cycle in rats, [2] suggesting that
persons with SCI may also experience polyuria at both day/night cycles as well.
Thus, a prospective study with appropriate controls (age, weight, blood pressure,
etc.) measuring both drink and urine volumes on an hourly basis may be
beneficial to elucidate this effect. Clinically, investigations have found reduced
sodium conservation in SCI individuals with higher levels of injury [163] and a
greater imbalance in day/night urine flow rates among those with cervical region
versus all other levels of SCI. [36] Further investigations are clearly needed to
better understand the role of circadian rhythms in fluid homeostasis.
The mechanisms behind SCI-induced polyuria are not yet fully
understood. However, recent studies have shown AVP, atrial natriuretic peptide
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(ANP) and their associated receptors vasopressin 2 receptor (V2R) and
natriuretic peptide receptor (NPRA), plus water channel aquaporin channel 2
(AQP2) and epithelial sodium channel (ENaC) are significantly altered after SCI
in rats. [35, 142] The significant decrease in AVP, specifically at night, has also
been shown in the clinical setting as well. [1, 144] Together, the changes in these
hormone peptides/receptors are in the direction that would indicate an increase
in urine production, and require further investigation for the elucidation of SCIinduced polyuria mechanisms.
Taken together, the findings reported here suggest that polyuria is induced
from the loss of supraspinal inputs to preganglionic sympathetic neurons
supplying the kidneys. This loss, as suggested by changes in a variety of
biomarker of fluid homeostasis including ANP, is further complicated by
alterations in cardiovascular dynamics with higher levels of SCI. The spacing
between T3 and T9 is not likely wide enough to detect significant differences in
24-hour urine volumes, or ANP/AVP concentrations, as is evident clinically in the
population with cervical level injuries. [163] Blood pressure and urine production
work in conjunction to keep each other balanced. There are several mechanisms
that work to maintain water/solute homeostasis by affecting blood pressure. For
example, studies focusing on hypertensive models, both animal and clinical,
have demonstrated that denervation of the sympathetic supply to the kidneys
results in abolishment of hypertension. [164, 165] Thus, alterations of the neural
control of the kidney is likely a contributing factor to orthostatic hypotension, a
common occurrence post-SCI. [166] Multiple studies have suggested that a
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higher level of injury may result in further impairment of cardiovascular and upper
urinary dysfunction. [163, 167] Therefore, a future study investigating an even
higher level of SCI (cervical) would likely be beneficial in elucidating the extent
that level of injury has upon SCI-induced polyuria.
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Figure 11:
Metabolic Cage Data Summary. Total 24-hour urine volume output (left graph)
demonstrates a statistically significant increase in urine production/passage at 1
wpi, and lasting through 6 wpi compared to pre-injury baseline volume and sham
volumes. The total 24-hour drink volume (right graph) indicates an absence of
statistically significant changes in water intake across all time points relative to
pre-injury and sham groups. (*p<0.05)
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Figure 12:
Suprachiasmatic nucleus (SCN) immunohistochemistry. A representative section
showing AVP-labeled cells at 400x in the SCN in both T3 sham and T3 SCI
animals (A). In (B), a modified plate from the Rat Brain Atlas illustrates the
location of the SCN within the hypothalamus. [168] The average quantified AVPlabeled cells/µm in the SCN was statistically significantly lower in the T3 SCI
animals compared to sham controls (C; p<0.05; T3 SCI (n=5), T3 sham (n=4)).
Values (shown in C) represent means; error bars represent standard error of
means.
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CHAPTER IV
EFFECT OF ANANTIN ON POLYURIA IN SPINAL CORD INJURED RATS

Introduction
Spinal cord injury (SCI) negatively impacts many systems, including
sexual, bladder, bowel, and cardiovascular functions. [9, 80, 140] Polyuria (the
overproduction/passage of urine), including nocturia (nighttime polyuria), is highly
prevalent amongst the SCI population, especially those with high level injuries.
[8, 169, 170] Although SCI-associated nocturia is thought to be precipitated in
part by the redistribution of fluid at nighttime from repositioning of the lower limbs,
pre-clinical models exhibit SCI-induced polyuria where redistribution of fluids is
not a factor, suggesting additional biological mechanisms exist. Recently, several
key biomarkers such as arginine vasopressin (AVP) and atrial natriuretic peptide
(ANP), along with several of their receptors including vasopressin 2 receptor
(V2R) and natriuretic peptide receptor A (NPRA), have shown to be associated
with SCI-induced polyuria in rats. [35, 142, 145] Desmopressin, a synthetic
analogue of vasopressin, has had limited results in the SCI population [171] and
is restrictive to certain age groups as it can cause water retention and
hyponatremia, [172] which is common amongst the SCI population. [163, 173]
Therefore, other therapeutics targeting different associated
mechanisms/receptors should be investigated.
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Under normal physiological conditions, NPRA is located in the lungs, adipose
tissue, heart/blood vessels, and the kidney and functions to promote vasodilation
and diuresis to decrease blood pressure. [174-176] Specifically in the kidney,
NPRA works to balance salt and water homeostasis by excreting salt into the
collection ducts which controls solute concentration of both urine and body
osmolality. Further, the ANP/NPRA system is directly related to the modulation of
cardiac hypertrophy seen in cardiovascular failure, [177] in addition to other
circulatory disorders seen in the SCI population. [178, 179] Recent research in
pre-clinical SCI rats with polyuria has demonstrated that kidney levels of NPRA
are significantly increased after SCI in addition to a significant increase in urinary
ANP levels, [35] which together likely exacerbate SCI-induced polyuria.
The NPRA antagonist anantin is a peptide isolated from Streptomyces
coerulescens, [180] and has been shown to acutely decrease urinary
production/output in non-SCI settings. [181, 182] Several studies investigating
effects of anantin have been either in vitro or acute (less than 24-hours). [183,
184] The increase in ANP and NPRA post-SCI [35] likely contributes to both low
blood pressure and polyuria seen after SCI. In the current study, anantin was
used as a potential treatment alone or in combination with activity-based
recovery training (ABRT), as ABRT alone has previously been shown to
significantly reduce the overproduction of urine, but not to pre-injury levels. [35]
Because blocking NPRA could potentially trigger an increase of blood pressure,
[111, 185] cardiovascular function was also examined. In addition, as inhibition of
NPRA may also precipitate a sodium/solute imbalance, [186, 187] serum sodium

73

and potassium levels were measured at pre-SCI, post-injury/pre-ABRT, and end
of study (post-ABRT) time points.
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Methods

Animals
All animal experimental procedures were carried out in accordance with
National Institutes of Health (NIH) guidelines and all protocols were approved by
the University of Louisville School of Medicine Institutional Animal Care and Use
committee. Adult male Wistar rats were used as the prevalence of SCI is
predominantly male. [188, 189] All rats were housed individually in an animal
room with a 12-hour light/dark cycle. After baseline data was collected and
injuries performed, animals were randomly assigned to either anantin (A) or
vehicle (veh) groups. Animals were further divided into forelimb trained (FT) or
non-trained (NT) sub-groups prior to the start of ABRT at 3 weeks post-injury
(wpi). Thus, four groups at the start of training were NT+A, NT+veh, FT+A, and
FT+veh. Experimenters were blinded to which rat was given the drug or vehicle.

Spinal cord injuries
After one week of acclimation to the vivarium and a week of baseline data
collection (metabolic cage data, blood draws, blood pressure recordings), all rats
(n=78; includes 30 for the dose-response portion) were anesthetized with a
mixture of ketamine (80 mg/kg, Ketoset®; Fort Dodge Laboratories, Fort Dodge,
IA) and xylazine (10mg/kg, AnaSed; Lloyd Laboratories, Shenandoah, IA),
administered intraperitoneally (ip), and underwent a moderate contusion injury at
the T9 spinal level as previously described [35, 190] Briefly, once animals were
fully anesthetized (surgical plane of anesthesia was confirmed using toe pinch
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and ocular reflexes), the surgical site was shaved and disinfected using 4%
chlorhexidine soap (Henry Schein). Animals were then placed on a heating pad
and ocular lubricant (OptixCare, Aventix) was applied. Animals then underwent a
T8 laminectomy for a T9 spinal level contusion using an IH impactor. [155] In
order to achieve a moderate contusion injury, a 225 kilodyne force with no dwell
time was used. The muscular layer was sutured, and skin closed with surgical
wound clips. Antibiotic (penicillin G, PenJect; Henry Schein Animal Health,
Dublin, OH) and analgesic (meloxicam, Eloxiject; Henry Schein Animal Health)
were administered subcutaneously as part of our standard post-operative nursing
care. [4, 97, 101, 190] Manual bladder expressions were performed using
Credé’s maneuver twice daily (early morning and late afternoon) until reflexive
bladder function was restored (4-6 days post-injury).

Metabolic Cages
Animals were housed in a six station Comprehensive Lab Animal
Monitoring System (CLAMS; Columbus Instruments, Columbus, OH) to monitor
24-hour urine output volume and drink volume following established protocols. [2,
4, 35] For pre-injury baseline measurements, animals were acclimated to the
metabolic cages by housing them for two separate 24-hour time periods, but only
the second measurement was recorded for analysis. Following injury, animals
were placed in metabolic cages once weekly until the terminal time point (8 wpi).
Food and water were available ad libitum.

76

Anantin treatment
The competitive antagonist of NPRA, anantin (United States Biological;
Salem, MA), was used to determine if inhibiting the activation of NPRA affects
polyuria after SCI. Previous studies using anantin as a method to decrease urine
production have been in acute and non-SCI-induced settings, [181, 191]
therefore we carried out a brief dose-response study in a small cohort of SCI rats
to identify the lowest effective dose. Doses of 0 µg (vehicle only, n=12), 15 µg
(n=3), 30 µg (n=3), and 60 µg (n=12) were administered intraperitoneally (i.p.)
once daily for two weeks, as SCI-induced polyuria presents by 7 days [145] postSCI. [2, 35, 142]
Based on the dose-response findings (see Results), aliquots of 60
µg/animal anantin dissolved in ddH2O (as saline may interfere with lyophilized
anantin efficacy, per manufacturer) or vehicle only were prepared and stored at 20 C until the day of use. Dosing with either 60 µg or vehicle was initiated on the
day of injury and continued throughout the study duration (8 wpi). The decision to
give the same dose of anantin/animal was made based upon the absence of any
correlation (Pearson test) between baseline weight and baseline 24-hour urine
volume (correlation coefficient=0.28; p=0.06). Injections were administered within
the same timeframe daily throughout the study (between 14:00-16:00 hours).

Treadmill training
ABRT on a treadmill (Exer-3R treadmill, Columbus Instruments,
Columbus, OH) was adopted from well-established protocols. [35, 190] However,
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only forelimb training (FT; n=24) and non-trained (NT; n=24) groups were used in
this experiment as no significant differences in 24-hour urine volume was found
previously between quadrupedal and forelimb only stepping groups. [35] Further,
in lieu of daily ABRT treadmill training, five consecutive days a week with two
days off on the weekend was used to reflect a more clinically relevant exercise
regimen. [52, 192] FT began at the start of week 3 post-SCI to allow ample time
for recovery. Animals were acclimated to the harness and treadmill. On day one,
the trained animals were put into harnesses and acclimated to the treadmill for
10 minutes. From there, each day the animals continued training with increasing
daily increments of 10 minutes until the full 58-minute protocol was achieved. For
this study, each animal reached acclimation by day 5. Trained animals continued
the 5 days/week protocol for 6 weeks, for a total of 30 sessions.

Blood pressure
Blood pressure was assessed using a non-invasive tail cuff method
(Harvard apparatus, LE5001). [191] Heart rate, systolic, diastolic, and mean
arterial pressure (MAP) were measured. To assure maximum comfort and
accurate recordings, a heating pad at a low setting was placed under the rat tube
holder to ensure proper vasodilation per manufacturer instruction. For pre-injury
baseline, animals were first acclimated to a quiet testing room (in cages) for 15
minutes. Then, each animal was handled by the examiner for a minimum of 5
minutes prior to being placed in testing tubes (Harvard apparatus, LE5022),
which were of a narrow design to limit movements. Animals were left in the tubes
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for a 15-minute period, then placed back in cages. For data collection, animals
were allotted 15 min for acclimation to the testing room each time, and 15
minutes for acclimation to tubes prior to recordings. The pressure cuff was
placed mid-tail to assure that the same general area was consistently used for
the weekly blood pressures recordings, which were timed to be taken prior to
training sessions. For each weekly session, the goal was to obtain a minimum of
three measurements but no more than five per rat for a weekly average reading.

Blood Sampling
Each animal underwent blood collections at three time points - pre-injury
(baseline), 2 wpi (post-SCI with anantin or vehicle treatment/pre-ABRT), and 8
wpi (terminal post-ABRT/NT with either anantin or vehicle). Animals were briefly
anesthetized with isoflurane (2%) for blood draws. Once ocular reflexes were
tested to assure anesthetic plane was reached, the base of the tail was shaved
for visualization of the lateral tail veins. Animals were placed on a heating pad,
and using an 18g needle the lateral tail vein was punctured and 0.5-0.7 mL of
blood was collected into serum separator tubes (BD microcontainer, Becton,
Dickinson and Co.). [193] The bleeding was stopped using light pressure with
sterile gauze, and if necessary styptic powder with benzocaine (Kwik-Stop, ARC
Laboratories). Serum was collected from samples centrifuged at 14,000 rpm for
15 minutes, then stored at -20C until analyses were performed.

Flame Photometry
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Flame photometry was carried out to calculate serum sodium and
potassium concentrations, as ANP/NPRA are key regulators of serum sodium
concentration. Flame photometry is used to accurately calculate concentrations
of solutes in liquid samples (e.g., serum, plasma). [194, 195] Standards were
diluted and used for calibration prior to any data recording, per manufacturer
instructions. After serum samples were acclimated to room temperature, each
sample was diluted 1:150 in accordance with manufacturer recommendations.
The flame photometer utilizes a nebulizer to aerosolize the diluted samples and
based upon the light intensity of the flame color that has characteristic
wavelengths for specific metal ions, a concentration is displayed.

White Matter Sparing
Histological analysis of the lesion site was carried out for calculation of
white matter sparing (WMS) as previously reported. [35, 97, 101, 102] Briefly, the
spinal injury epicenter, in addition to ~2 spinal levels above and below, was
removed from animals’ post-perfusion and sectioned at 20 µm thickness prior to
staining with Luxol fast blue and cresyl violet. The lesion site and WMS were
captured with a Nikon E400 microscope and analyzed using Spot Advanced
software (Diagnostic Instruments, Sterline Heights, MI). The percent WMS was
calculated by dividing intact white matter remaining at the lesion epicenter by the
average intact white matter at areas rostral and caudal the injury site where white
matter was more intact. The average of two areas ≥2 mm both rostral and caudal
was used for intact white matter.
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Statistical Analyses
One-way repeated measures ANOVA analyses were performed to
compare the four treatment groups (NT+A, NT+veh, FT+A, FT+veh) for 24-hour
urine volume, MAP, and serum sodium/potassium concentrations across
specified time points. One-way ANOVA analyses were performed to compare
BBB and WMS between groups. To reduce variability inherent with single time
point measures of 24-hour void volume and blood pressure, pairs of consecutive
recordings were averaged together to yield 5 different data bins: Pre-SCI
baseline, 1-2 wpi (post-SCI, pre-training), 3-4 wpi, 5-6 wpi, and 7-8 wpi, where
training occurred from 3-8 wpi. Pearson correlations studies were carried out to
distinguish if any significant correlations between WMS, BBB, or weight and 24hour urine volumes were present, in addition to serum sodium and MAP. All
statistical analyses were carried out using SigmaStat v3.5 (Systat Software)
where significance was determined for p<0.05 for all statistical tests utilized. All
data was checked for outliers using the online GraphPad calculator (Grubb’s
test).
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Results

Anantin Dose-Response Pilot
To determine the minimum effective dose of anantin on 24-hour urine
volume, an initial pilot experiment was done comparing SCI rats treated with
anantin, at doses of 15 µg (n=3), 30 µg (n=3), and 60 µg (n=12), with vehicle-only
treated injured animals (n=12). As illustrated in Figure 13, after both one and two
weeks of daily i.p. anantin or vehicle injections, all SCI groups demonstrated a
significant increase in 24-hour urine volume compared to pre-SCI baseline levels.
The 60 µg anantin treated animals, however, produced a significantly lower
average urine volume relative to vehicle treated animals. Note that the 24-hour
drink volumes were not significantly different between any of the groups or at any
time point (data not shown).

Experimental Groups
Complete data sets were obtained for 44 out of 48 rats. Details about each
group including injury parameters are summarized in Table 2. No significant
differences were found between groups with respect to baseline body weight,
impactor force and displacement, and two-week pre-ABRT BBB, indicating
successful randomization of the rats. Although each group initially had an N of
12, several rats from different groups were eliminated from the study due to
either complications of the injury itself or severity was too mild and yielded
significant outliers for BBB (score of 19 or higher) and/or WMS (89% or higher).
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Metabolic cage
The Day 4 residual urine volumes (Table 2) did not differ between anantin
and vehicle treated groups. Each of the groups demonstrated significant
increases in 24-hour urine volumes at 1 wpi, and each of the weeks following
through 8 wpi (Figure 14). There was a significant decrease in the average
change of void volume in the FT+A and FT+veh animal groups compared to
NT+veh at 5-6 wpi and both the NT+A and NT+veh animal groups at 7-8 wpi. Of
note, the drink volumes for each of the groups did not differ from each other, or at
any of the time points (mean of 34.3 ml at baseline; data not shown).

Blood pressure
At-rest heart rate (measured in beats per minute (BPM)), systolic,
diastolic, and mean arterial pressure (MAP) were all recorded from each animal
once weekly using a non-invasive tail cuff apparatus. There was a significant
decrease in blood pressure but not heart rate post-SCI, which lasted chronically
(MAP data provided in Figure 15). Note that pre-training blood pressure was
significantly lower for vehicle versus anantin treated rats (examined as two larger
groups since the time point is pre-training). However, this effect was not
observed at any of the remaining time points, regardless of training group (no
significant differences in heart rate as well across any of the time points or
between any of the animal groups).

Serum sodium and potassium
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There was a significant decrease in relative serum sodium levels in all four
animal groups at 8 wpi compared to baseline levels (Figure 16A). However, there
was no significant change at 2 wpi in serum sodium compared to baseline.
Further, neither anantin nor FT had any effect on serum sodium levels, as there
were no significant differences between any of the groups at either 2 or 8 wpi. In
contrast with sodium, serum potassium levels were significantly increased at 2
wpi in all four animal groups relative to baseline levels (Figure 16B). However, at
8 wpi, there was no significant difference in any of the groups compared to
baseline. As with serum sodium levels, neither anantin nor FT had any effect on
serum potassium levels.

White matter sparing
The average percent WMS was 13.8% ± 1.3%, 21.9% ± 2.12%, 17.5% ±
4.3%, and 23.5% ± 3.7% for NT+A, NT+veh, FT+A, and FT+veh, respectively.
There were no significant differences in WMS between any of the groups.
Further, Pearson correlations revealed that there were no significant correlations
between WMS and 24-hour void volume change (r=0.20, p=0.21), 24-hour drink
volume (r=-0.18, p=0.24), terminal body weight (r=0.11, p=0.47), 8 wpi MAP
(r=0.16, p=0.31), sodium levels (r=-0.10, p=0.52) serum potassium (r=0.21,
p=0.19).
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Discussion

Current interventions for SCI-induced polyuria include fluid restriction
(most common) and desmopressin (DDAVP), which has restricted use and
limitations. [171, 172] An expansion of the small number of available treatment
options needs consideration, as the frequent daily practice of restricting fluids
can lead to a myriad of other problems, such as dehydration and autonomic
dysreflexia by way of bowel impaction. [196] Although the complete mechanism
behind SCI-induced polyuria is still unknown, several related biomarkers have
previously been identified, [35, 142, 145] including NPRA, which was targeted
with the receptor antagonist anantin in the current study both alone and in
combination with ABRT.
Although our initial pilot study revealed animals treated with 60 µg of
anantin given i.p. voided lower volumes than those treated with vehicle during the
first two weeks after SCI, both groups had significant SCI-induced polyuria. The
rationale of incorporating FT into this study was to determine the efficacy of a
combinatorial therapy approach with treatment of anantin in conjunction with
ABRT, which has shown to be effective in decreasing 24-hour void volumes, but
not back to pre-injury baseline levels [35]. Although there was a significant effect
of FT on void volume, no effect was found for anantin treatment in conjunction
with FT. However, initially post-SCI, a small but statistically significant effect was
found for anantin treatment on blood pressure.
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There are several potential explanations as to why anantin did not have an
effect on 24-hour void volumes. Firstly, the bioavailability (including half-life and
time to reach kidney NPRA) of i.p. anantin is unknown, and therefore the dose
given may not have had a lasting effect on urine production. Also, the dosage of
60µg/animal may have been too low, as this dosing was derived based upon
published studies that utilized either intravenous or direct application of the drug.
One study that used an anantin dosage of 100µg/kg body weight [197] did not
report route of administration or void volumes. Additionally, NPRA may not be a
significant driver for SCI-induced polyuria, as kidney NPRA levels have recently
been shown to fluctuate after SCI, [145] suggesting that other factors are likely to
be more prominent for maintaining the overproduction of urine volume.
Another key finding of this study was the significant chronic decrease in
MAP. The presence of hypotension in awake rats at rest is clinically relevant, as
hypotension is common in the SCI population. [9, 167] Several studies
investigating MAP in rats after SCI that utilize radio telemetric pressure
transducer devices with pressure probes placed directly in the abdominal aorta
have yielded different results, which may be explained by outcome differences
between central MAP versus peripheral MAP recordings. [198, 199] It is
important to note that clinically, it is thought that central MAP is more accurate as
it is more closely related to organ supply and health. However, SCI is more
nuanced than typical cardiovascular issues, as demonstrated by the fact that
persons with SCI (and likely SCI animals as well) [200] rely on the reninangiotensin-aldosterone system (RAAS) more than able-bodied individuals. [200-
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204] Moving forward, using a non-invasive tail cuff procedure to record at-rest
blood pressure would be beneficial in monitoring cardiovascular health (both
blood pressure and heart rate), similar to how BBB scores are commonly utilized
in rodent SCI research.
Additional study results indicate that there was a chronic decrease in
serum sodium, and significant acute increase in serum potassium. Previously, we
have reported that the serum osmolality was increased acutely (2 wpi), [142]
which suggests that there was an excess of serum levels of solutes, such as
sodium or other electrolytes. Although no significant effect of anantin treatment
on serum sodium levels was found in the current study, there was a significant
decrease in serum sodium relative to pre-injury baseline chronically. A decrease
in serum sodium is also found clinically, where hyponatremia is associated with
hypotension after SCI. [205] Further, hyponatremia has been associated with
disrupted descending renal sympathetic circuits, as seen in SCI-induced
hypotension/cardiovascular dysfunction. [205] Thus, our data is likely indicative
of the severe dysfunction in mechanisms regulating water/solute homeostasis,
such as AVP/V2R, epithelial sodium channel (ENaC), [145] or potential
disruptions in the RAAS after SCI. Although further research is necessary to
decipher the extent that RASS is disrupted after SCI, it has already been
demonstrated that the AVP/V2R and ENaC system is significantly disrupted after
SCI. [35]
The flame photometry findings also indicate the presence of a significant
increase in potassium at 2 wpi, but not at 8 wpi. The most common causes for
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hyperkalemia are kidney disease, urinary tract/kidney infections, drug
administration, cardiovascular ischemia, and significant muscle atrophy. [206]
However, both anantin and vehicle animals demonstrated significant increases in
potassium, therefore it is unlikely the increase in serum potassium was due to
anantin administration. The only reported cases of hyperkalemia in the SCI
population has been associated with succinylcholine administration, a paralytic
drug commonly given for anesthesia, which our rats did not receive. [207] Thus,
possible causes for the significant spike in serum potassium is muscle atrophy
and/or kidney dysfunction. Muscle atrophy is not as likely due to the timing of the
increase (during the acute/sub-acute stage post-SCI). Kidney dysfunction may
occur via several different mechanisms. The increased potassium at 2 wpi may
result from spinal shock which could relate to the presence of hematuria in rats
shortly after SCI. [95] Although hematuria resolves within a week, there may be
lasting damage to the kidney. Additionally, spinal shock after injury significantly
disrupts bladder function, resulting in an initial state of detrusor areflexia and the
need to empty using the Crede method, which could cause urine to flow
retrogradely through the ureters and damage kidney tissue. Further investigation
on the timeline of changes in serum (and urinary) potassium and sodium may be
important in not only determining SCI-induced polyuria mechanisms, but also
cardiovascular health, as solute/water balance is heavily regulated by the
kidneys.
There is evidence that both hyponatremia and orthostatic hypotension is
prevalent in the SCI population, which is supported by the findings presented
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here. [9, 208] Although there was not a significant correlation between MAP and
serum sodium levels in this study, using these methods for future studies could
be useful in elucidating treatments for alleviating these potentially harmful
conditions. Hyponatremia can cause attention deficit, gait instability, and
osteoporosis. [209] Further, the results of this study indicate that ABRT does not
alleviate hyponatremia, suggesting that other treatment options should be
explored in this regard.
Together, the current results suggest that NPRA alone or in combination
with ABRT is not an ideal candidate as a target for therapy to alleviate SCIinduced polyuria, as other complex mechanisms involving multiple systems are
likely involved, which requires further investigation.
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Table 2
SCI Impactor Parameters and Assessment Outcome Values
Injury force

Displacement

(kdyne)

12
11
12
9

Group

n

NT+A
NT+veh
FT+A
NT+veh

4-day
residual vol

14 dpi

(μm)

Baseline
weight

BBB

Terminal
BBB

219 ± 3.80

1331 ± 229

337 ± 22

1.85 ± 0.59

9.8 ± 1.2

11.8 ± 3.8

234 ± 24.7
224 ± 14.8
227.6 ± 16.9

1417 ± 170
1387 ± 163
1375 ± 210

331 ± 32
346 ± 23
342 ± 18

2.13 ± 0.59
2.7 ± 0.67
1.4 ± 0.44

11 ± 0.97
10.8 ± 0.62
11.8 ± 1.11

11.7 ± 3.9
10.5 ± 1.8
12.8 ± 3.6

No significant differences; p>0.05. Values are means ± standard deviation
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Figure 13:
Metabolic cage data from anantin pilot study. At 2 wpi, the change in 24-hour
void volumes (average 10.47 mL) from baseline were significantly increased
compared to baseline levels for both anantin and vehicle (veh) treated animals
(*p<0.05). The testing of responses to different dosages of anantin revealed
significantly lower void volumes with 60 µg than the veh treated animals at 2 wpi
(#p<0.05). Values represent means of volume change with error bars
representing standard error.
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Figure 14:
Metabolic Cage Data Summary. The average change in 24-hour void volume
output demonstrates a statistically significant increase in urine
production/passage at 1 wpi-8 wpi compared to pre-injury baseline (average 8.01
mL) levels for all animal groups and at every time point post-SCI (*p<0.05).
Comparisons between early, mid, and later training time points reveal a
significantly lower void volume change for the FT+veh animal group mid-training
and both FT animal groups by the end of training relative to the NT animal
groups (#p<0.05). Values represent means of change in void volume from
baseline with standard error.
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Figure 15:
Change in MAP after SCI. There is a significant decrease in MAP post-SCI in
both anantin (A) and vehicle (veh) treated animals (*p<0.05; relative to Pre-SCI).
Note that because training did not commence until 3 wpi, animals were grouped
together based on anantin/veh treatment, then separated by group once ABRT
began. The veh treated animal group demonstrated a significantly lower MAP
than the anantin treated animal group post-injury, prior to ABRT (1-2 wpi time
point; #p<0.05). Values represent means of MAP with standard error.
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Figure 16:
Changes in serum sodium and potassium. The average change in relative serum
sodium levels were statistically significantly lower at 8 wpi (post-training)
compared to pre-injury baseline and 2 wpi (pre-training; left graph; *p<0.05). The
average change in serum potassium levels were significantly increased at 2 wpi
(pre-training) compared to pre-SCI baseline levels in both anantin (A) and vehicle
(veh) groups, but there was no significant difference in potassium levels at 8 wpi
compared to pre-SCI baseline levels for either group (right graph; *p<0.05),
regardless of training (forelimb trained [FT] versus non-trained [NT]). Values
represent means of groups with standard error.
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CHAPTER V

GENERAL DISCUSSION AND FUTURE DIRECTIONS

The goal of this project was to further investigate the mechanisms behind
SCI-induced polyuria, as the only information known clinically was that 1) there is
a significant lack of diurnal variation of AVP observed in the SCI population and
that 2) the use of compression socks throughout the day improved nocturia in
one study. However, it is unknown what causes the disruption of AVP or what
time point after injury it presents. Further, animals do not undergo the same
amount of fluid redistribution that humans do, but still present with SCI-induced
polyuria, suggesting that while compression stockings may partially reduce
nocturia, it may not be improving physiological mechanisms associated with SCIinduced polyuria, such as AVP production. The results from this pre-clinical study
identify multiple key biomarkers, including ANP, that could be investigated in
human SCI as well. Further, the effect SCI has on hypothalamic nuclei requires
further investigation. This study has demonstrated that SCI-induced polyuria
likely involves several systems: hypothalamic/circadian, renal, sympathetic, and
cardiovascular systems.
Previously, an increase in ANP and decrease in AVP were found at 2 wpi,
and 10 wpi, [7, 35] while fluctuations in NPRA, V2R, AQP2, and ENaC were
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found to be altered at 10 wpi. [35] A timeline in the current study showed
changes in key biomarkers as early as 7 dpi, but not during the initial acute
phase (3 dpi). Also, at 7 dpi through 42 dpi, V2R is significantly decreased.
However, NPRA does not follow the same trend and is only significantly
increased at 14 dpi and 42 dpi, suggesting that the changes in these too are not
being controlled by each other, as ANP/NPRA activation inhibits AVP release.
Further, the fluctuations in AQP2, ENaC, AVP, and ANP at the sub-acute time
point support the hypothesis that the overproduction of urine is secondary to the
injury itself, but continue chronically, further evidence of how SCI is a progressive
and ongoing injury. Additionally, variability of biomarkers seen in the current and
previous studies [7] suggest that the system is likely attempting to correct itself to
achieve homeostasis. However, since SCI affects multiple system, a balanced
system is not achieved and requires therapeutic/rehabilitative interventions, such
as ABRT. [35]
Circadian disruption of AVP, specifically low levels of circulating AVP, has
been well established in the SCI population. [1, 8, 39] Although the findings from
this study that AVP is significantly decreased after SCI (both T3 and T9
contusion) is not a novel one, its importance should not be undervalued.
Interestingly, a novel finding in both T9 and T3 animals was the significant
decrease in AVP-labeled cells in the SCN, suggesting that there are further
significant changes within the hypothalamus after SCI, which has been supported
by several studies investigating circadian genes post-SCI. Further, these
changes line up with the significant decrease in serum AVP, confirming that
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hypothalamic changes are at least in part responsible for the disrupted diurnal
variation seen in AVP production and urine production specifically at night.
Although the synthetic analogue of AVP, desmopressin (DDAVP) exists and is
used clinically, chronic use may not be beneficial, but instead harmful. Although
the use of DDAVP is successfully used primarily in adolescent children who
display chronic bed-wetting with success, SCI-induced polyuria has a more
complex etiology. Utilization of DDAVP in the SCI population is different from its
use in other settings, as SCI results in far more complications, such as
cardiovascular and hormonal dysfunction. Further, the risk of hyponatremia is far
greater in the SCI population, and therefore DDAVP should be used with extreme
caution. Therefore, DDAVP is not an ideal pharmacological intervention to treat
SCI-induced polyuria.
The significant findings from the T3 study validate that SCI-induced
polyuria is still present when the local spinal circuitry of sympathetic fibers is left
intact, and thus only descending supraspinal renal sympathetic pathways are
disrupted. Further, the results indicate that similar mechanisms, such as
ANP/AVP dysregulation are likely driving SCI-polyuria, regardless of injury level.
It may be interesting for future studies to investigate a timeline of alterations in
biomarkers and associated functional deficits similar to that of Chapter II and IV.
For example, it is anticipated that blood pressure and related biomarkers of T3
level SCI animals would also be significantly impacted, lasting chronically. [210]
Clinically, a higher incidence of SCI-induced polyuria, in addition to
cardiovascular disorders, are reported for individuals having cervical levels of
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SCI. The link to cardiovascular health and renal health are very closely related,
suggesting that the drop in MAP seen in both pre-clinical animal and clinical
settings is also associated in SCI-induced polyuria. The results from Chapter IV
(anantin study) revealed that MAP is significantly and chronically reduced.
However, the results from Chapter II revealed that there are fluctuations in most
of these biomarkers as previously mention, suggesting that while cardiovascular
health may be associated with SCI-induced polyuria, additional mechanisms are
present as well. While the results presented here suggest a T3 injury does not
increase the risk of developing SCI-induced polyuria, a study involving a cervical
injury, as well as a lower T13 injury, and investigating their effects on
aforementioned biomarkers would be beneficial to further identify the importance
level of injury has on SCI-induced polyuria. Taking what has been reported
clinically, it would be expected that a lower T13 injury, well below any
sympathetic pathways to the kidney, compared to a C4 injury, which would not
only effect descending sympathetic fibers to the kidney but also the sympathetic
circuitry for the heart, in addition to respiratory impairment, would likely result in
significant differences in both cardiovascular and upper urinary tract health. [36,
211, 212]
Of further relevance for inter-system interactions is that the significant
decrease in MAP matches the decrease in AVP (found in Chapter II), which is a
potent vasoconstrictor. However, NPRA levels within the kidney are not always
upregulated, suggesting it may not be an ideal target for pharmacological
therapy. This outcome also likely explains why there was no effect found with
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anantin treatment compared to vehicle only. Although the bioavailability along
with the dosing of anantin is a potential reason as to why an effect was not
observed, taken with the results from Chapter II, it is more likely that targeting of
NPRA alone is not sufficient. Additionally, it may also be that the significant
increase of ANP is too great for anantin to make an impact on 24-hour void
volume. However, as previously reported, ABRT has the ability to reverse the
change of kidney receptors (NPRA, V2R, AQP2, and ENaC) seen after SCI, to
sham levels. [35] Although kidney receptors were not investigated in the anantin
study, it would be hypothesized that the ABRT animals demonstrated this same
effect, which is why we saw a significant decrease in 24-hour void volume
change compared to NT animals, but not back to pre-SCI baseline levels. Based
upon these findings, it is likely that a combined treatment modality, such as
ABRT in addition to pharmacological interventions is necessary to fully alleviate
SCI-induced polyuria.
Although anantin treatment compared to vehicle treatment did not result in
any significant findings, the use of flame photometry proved useful for future
studies. As previously mentioned, there was a significant increase in serum
potassium at 2 wpi, and a significant decrease in serum sodium at 8 wpi in all
animal groups. Under normal physiological conditions, any excess of circulating
potassium in the blood is excreted by the kidneys through urine production.
Several factors can contribute to an increase in serum potassium, including
muscle/tissue degradation, certain disorders (Addison’s disease), certain drugs
(angiotensin-converting enzyme inhibitors), and acute/chronic kidney
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failure/disease. [213] Although the major basis for the significant increase in
serum potassium compared to pre-injury levels is likely the injury itself and
subsequent muscle loss, this increase may contribute to kidney damage. The
extent of kidney damage resulting from acute/sub-acute SCI is still unknown and
requires further investigation. A future study that investigates the timing of when
an increase in serum potassium begins post-SCI utilizing a temporary
intravenous cannula for acute SCI, and daily blood draws for sub-acute
samplings would be useful. Further, because the volume necessary for flame
photometry is low, serum sodium should be investigated as well, as it has been
reported that acute SCI causes a significant decrease in serum sodium. [173,
205] Although there was no significant decrease in serum sodium at 2 wpi in this
study, there was a chronic decrease, which supports existing literature that
hyponatremia is a major issue in the chronic SCI setting. [214, 215] Thus, it is
likely that the increases in NPRA and ANP due to SCI are driving chronic
hyponatremia, which is a novel finding. However, a future study investigating
fluctuations in ANP, NPRA, and serum sodium are necessary to confirm this
hypothesis.
Taken together, the results of this dissertation have further clarified
several potential mechanisms and the timing of which they occur regarding to
SCI-induced polyuria. Further, the data advance our current knowledge of SCIinduced polyuria that can be used in future pre-clinical animal models and in the
clinical SCI setting as well. Although it is well-established that AVP levels are
significantly decreased in the human SCI population, there have been no
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published studies in the clinical setting on ANP levels (either urinary or serumderived), which is a key biomarker for both cardiovascular and urological health.
Further, ANP is antagonistic against the RAAS and sympathetic control. [216] It
has been reported that the SCI population rely heavily on the RAAS for
cardiovascular homeostasis, specifically regarding to postural changes. [67, 217,
218] The SCI research community would benefit from understanding if ANP is a
significant driver for SCI-induced polyuria, or rather a symptom of a greater
systemic disruption. Under normal physiological conditions, ANP is released only
when cardiomyocytes within the atria of the heart are stretched in response to an
increase in blood volume. [219] It is counter intuitive that ANP levels are
increased after SCI, as low blood pressure is a major occurrence and concern
after SCI. The underlying cause of the increase in ANP/NPRA seen in this and
previous studies may be a further indication of a homeostatic system attempting
to correct itself. Interestingly, this study also revealed that SCI rats also
demonstrate hyponatremia at the chronic time point. In the future, both
ANP/NPRA should be investigated in combination with serum/urinary sodium
levels. The results from this study would suggest that the lack of supraspinal
input to the cardiovascular system below the level of injury, including but not
limited to the kidneys, causes a significant drop in MAP. However, all the studies
reported here utilized an injury that would not directly impact the circuitry of the
heart, suggesting that the heart is able to respond normally to blood pressure
increases caused by mobility in rodents post-SCI. The acute increase in blood
pressure releases ANP, thus causing the excretion of sodium and water. Further,
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as orthostatic hypotension is well-established in the human SCI population, as it
is established in this study as well, chronic low blood pressure results in an
upregulation of NPRA in the kidney due to desensitization. This chronic
disbalance is likely why fluctuations in NPRA and ANP were observed post-SCI.
These data could explain why the use of anantin to block NPRA was not effective
enough to significantly decrease void volumes. Therefore, further studies are
needed to identify further biomarkers to target for pharmacological interventions.
Another important finding from the anantin study was the significant
decrease in void volume change with ABRT. Similar to previous reports, there
was a significant decrease in 24-hour void volumes after the administration of
ABRT. The mechanisms behind how ABRT improves SCI-induced polyuria is still
unclear, but it is likely that it helps the system regain homeostasis by regulating
specific biomarkers as a previously published study has pointed out. [35]
However, further mechanisms are likely involved as well and require further
investigation to elucidate how exercise, and to what extent or types of exercise is
needed to reduce SCI-induced polyuria. It is important to note that clinically,
ABRT is administered for 70 sessions, rather than a set number of days per
week. Because this study utilized a training routine of 30 sessions with significant
results, it may be beneficial to investigate the effects of different training plans,
such as two days/week for 70 sessions compared to once/day for 70 sessions.
How long the training effect lasts if a stoppage occurs (re patient compliance to a
particular exercise regimen) is another issue that needs to be addressed.
Although the results of this study revealed that 30 sessions of ABRT (5
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days/week) was not sufficient to improve MAP, it would be beneficial to continue
monitoring at-rest peripheral blood pressure in conjunction with different amounts
of ABRT as a primary outcome measure, as cardiovascular health is closely
related to urologic health.
Another method that could be utilized in future studies to investigate
important mechanisms and therapeutic targets for SCI-induced polyuria is the
use of knockout (KO) mouse models. Although NPRA would appear to not be an
ideal target for therapy based off the results from this study, there were
limitations that were possibly confounding the results (such as the bioavailability
of anantin and dosing). Studies report that an NPRA KO model produces a lower
urine flow in response to ANP injections compared to wild type controls. [187]
Because we have found that ANP is increased after SCI, it is expected that an
NPRA KO would decrease the effect of SCI-induced polyuria. However, because
there are other mechanisms and biomarkers at play, the 24-hour void volumes
may not return to pre-injury baseline levels. Therefore, the use of other KO
mouse models, such as V2R, or ENaC KO would further confirm their role in SCIinduced polyuria.
Further investigation outside of SCI may also illuminate potential
mechanisms on SCI-induced polyuria. For instance, the incidence of nocturia in
patients with multiple sclerosis (MS) is considered one of the most bothersome
lower urinary tract symptom affecting quality of life, similar to the SCI population.
[73, 74] Currently there are several animal models for MS, the main one being an
experimental autoimmune encephalomyelitis (EAE), which can be achieved
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through manipulation in either mouse or rat models. [220, 221] Therefore, it may
be beneficial to study polyuria in these animal models, and investigate whether
the biomarkers associated with SCI-induced polyuria overlap with those in the
EAE model. Although MS and SCI are two very different and complicated whole
system disorders, there are similarities between the two. Both MS and SCI affect
primarily the central nervous system (CNS), which unlike the peripheral nervous
system (PNS), is unable to functionally repair itself. Investigation of MS models
compared to SCI models in areas such as cardiovascular function may also be
beneficial to both fields.
Although AVP, ANP, V2R, NPRA, and ENaC are key biomarkers involved
in both cardiovascular and urinary homeostatic control, the RAAS is another
mechanism that helps regulate both blood pressure and urinary output. Upon
normal physiological function, the RAAS is a hormonal system that is comprised
mainly of renin, angiotensin II, and aldosterone and is regulated primarily by
renal blood perfusion. Renin is released in the kidney in response to either
decreased sodium, reduced perfusion pressure, or sympathetic stimulation of
specific kidney areas (juxtaglomerular apparatus). As previously mentioned, the
release of renin is inhibited by the release of ANP, which we have found to be
significantly increased at various time points post-SCI. Angiotensin II comes from
the cleavage of angiotensinogen by renin into angiotensin I, which is then
converted to angiotensin II by angiotensin converting enzyme (ACE). Angiotensin
II has multiple effects systemically, such as vasoconstriction of arterioles, sodium
reabsorption within the kidney, release of noradrenaline, release of AVP by the
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hypothalamus/pituitary gland, and the stimulation of aldosterone. Aldosterone
mainly effects the kidney by increasing ENaC and promote sodium reabsorption,
which may also result with a reduced level of potassium. Although there have
been several studies investigating the separate components of RAAS after SCI,
[202, 205, 222] there is yet to be an association demonstrated between RAAS
and SCI-induced polyuria. Further, there is evidence that after SCI, liver function
is significantly disrupted, potentially leading to metabolic disease. [223-225],
which may also disrupt the RAAS further. It would be beneficial to determine the
effect of chronic SCI on circulating renin, angiotensin II, aldosterone levels, along
with associated angiotensin AT2 receptor, which has been shown to be
neuroprotective after experimental SCI, and other RAAS-associated biomarkers.
[226] Understanding these potential disruptions will not only further illuminate the
mechanisms behind SCI-induced polyuria, but also provide other potential
targets to improve quality of life for SCI individuals.
An additional potential therapy to alleviate SCI-induced polyuria is epidural
stimulation, in conjunction with exercise therapy. Currently, there are many
clinical and pre-clinical animal studies utilizing epidural stimulation as a
rehabilitation therapy to improve multi-systems after SCI. [227-230] There is
evidence that epidural stimulation improves cardiovascular health, including
better regulation of MAP. [229] A prospective study including SCI patients that
have reported nocturia and epidural stimulation as a treatment modality would
potentially lessen the incidence of SCI-induced polyuria but could also help
elucidate the extent cardiovascular health has on SCI-induced polyuria.

105

In conclusion, this dissertation research has provided further knowledge
on mechanisms responsible for SCI-induced polyuria. Although seemingly
simple, an overproduction of urine seen after SCI likely has multiple causes and
is a symptom seen due to multi-systems failure, including hormonal imbalance,
hypothalamic disruptions, cardiovascular dysregulation, significantly disrupted
solute handling, and damaged supraspinal sympathetic pathways. Future studies
in both clinical and pre-clinical animal settings investigating both cardiovascular
and urinary function will benefit from the data presented from this work.
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